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CHAPTER I 
INTRODUCTION 
Chromium (III) is an essential nutrient required for 
normal glucose, lipid and nucleic acid metabolism. In early 
experiments, Schwarz and Mertz discovered that trivalent 
chromium is an essential trace element in preventing and 
reversing glucose intolerance (Schwarz and Mertz 1957, 
1959). Chromium supplementation of patients on total, 
parenteral nutrition (TPN) showed a significant improvement 
in several diabetic-like symptoms which were not improved by 
conventional treatments, such as use of exogenous insulin 
(Jeejeebhoy et al. 1977, Freund et al. 1979, Mossop 1983). 
Chromium supplementation affected children with protein 
calorie malnutrition (Hopkins et al. 1968, Gurson & Saner 
1971), diabetics {Glinsmann & Mertz 1966, Nath et al. 1979, 
Mossop 1983), elderly (Levine et al. 1968), individuals of 
varying ages with marginally impaired glucose tolerance 
{Anderson et al. 1983) and hypoglycemic patients (Anderson 
et al. 1984) • 
In lipids, chromium affected serum cholesterol 
(Schroeder & Balassa 1965, Abraham et al. 1982), the ratio 
of cholesterol:HDL-cholesterol (Riales & Albrink 1981), 
arterial plaque size (Abraham et al. 1980), and serum 
1 
insulin {Nath et al. 1979, Mossop 1983, Anderson et al. 
1984). All of these factors affected the development of 
atherosclerosis. 
Glucose tolerance factor {GTF) was considered to be a 
trivalent chromium compound {Toepfer et al. 1977) first 
found in brewer's yeast. Studies showed the improvement of 
impaired intravenous glucose tolerance {Schwarz and Mertz 
1959, Tuman et al. 1978) and the enhancement of glucose 
metabolism in rat epididymal fat pad (Mertz et al. 1961) by 
GTF compound. However the chemical structure of GTF is not 
yet known. 
The interaction between chromium and nucleic acids was 
first demonstrated by Herrmann and Speck (1954). Later 
Wacker and Vallee (1954) observed that chromium content was 
high in nucleic acids and the bond between chromium and 
nucleic acids was strong. Chromium enhanced RNA synthesis 
both in vitro (Okada et al. 1982) and in vivo (Okada et al. 
1983). Chromium accumulated in the nucleotide may 
participate in gene expression (Okada et al. 1984). Cr(III) 
possibly stimulated in vitro RNA synthesis by binding to DNA 
(Okada et al. 1982). 
The relationship between copper and lipids was first 
found by Klevay (1973). His study showed that copper 
deficiency increases serum cholesterol in rats and dietary 
zn:cu ratio influences the animal model of copper 
deficiency. Other studies have shown hypercholesterolemia in 
copper deficiency (Allen and Klevay 1978a, 1978b, 1978c, Lei 
2 
i 1978). Copper also is an essential component of superoxide 
I 
dismutase (SOD) which protects lipid cell membrane 
structures from oxidation by free oxygen radicals (McCord 
and Fridovich 1969). Animal studies have shown that SOD 
activity in chicks (Bettger et al. 1979), pigs (Williams et 
al. 1976), and rats (Paynter et al. 1979) is related to 
copper nutrition. Therefore SOD activity can be considered 
as an potential index of copper nutritional status. 
CH is a traditional Chinese herb which has been used in 
hyperlipidemia and diabetes in China for centuries. But 
little is known about it's physiological and chemical 
properties. In recent years its hypolipidemic effects have 
been investigated in pigeons (Guo and Song 1986), rats (Niou 
et al 1988), Japanese quail (Wang and Jin 1984), and mice 
(Cheng et al. 1988, Cheng and Stoecker 1990). All the 
results showed a significant hypocholesterolemic effect. 
Purpose and Objectives 
The purposes of this study are: 
(1) to test the hypoglycemic and hypolipidemic effects of 
chromium in mice. 
(2) to select a Chinese herb with high IPA (insulin 
potentiating activity). 
(3) to test the hypoglycemic and hypolipidemic functions 
of a Chinese herb with high insulin potentiating 
activity (IPA) in mice. 
3 
(4) to investigate the effects of er on nucleic acids in 
rats and guinea pigs. 
Hypotheses of Research 
Hl. There will be no significant differences in blood 
glucose or cholesterol between Cr-supplementation and er-
depletion groups in mice. 
H2. There will be no significant differences in blood 
glucose or cholesterol due to CH extract-supplementation. 
HJ. There will be no significant differences in blood 
glucose or cholesterol due to CH extract- or cu-
supplementation in mice fed a hypercholesterolemic diet. 
H4. There will be no significant differences in the blood 
glucose or cholesterol of mice fed a hypercholesterolemic 
diet and supplemented with single CH fractions. 
HS. There will be no significant differences in the blood 
glucose or cholesterol supplemented by the combination of CH 
fractions in mice fed a hypercholesterolemic diet. 
H6. There will be no significant differences in the blood 
glucose and cholesterol by the supplementation of fraction 1 
of CH in the obese mice. 
H7. There will be no significant differences in hepatic RNA 
and DNA between er-supplementation and er-depletion groups 
of rats. 
HS. There will be no significant differences in hepatic RNA 
and DNA between Cr-supplementation and Cr-depletion groups 
of guinea pigs. 
4 
Limitations 
In this study, we will investigate the metabolism of 
glucose, lipids and nucleic acids in Cr-depleted and Cr-
supplemented animals. Making the Cr-depleted animal model is 
one of the limitations in this study because of the 
I 
I 
pJssibility of external chromium contamination. Another 
limitation is the unavoidable differences in IPA and 
concentrations of Cr among different batches of the Chinese 
herbs during the entire experiment. 
Definition of Terms 
1. Chromium (III) - Trivalent chromium is the most 
stable valence state of chromium. It has a strong 
tendency to form coordination compounds, complexes, 
and chelates. Chromium (III) is an essential 
elements for animal and humans. 
2. Glucose intolerance - Glucose intolerance is one of 
the first measurable signs of chromium deficiency 
and diabetes. Glucose intolerance may be seen in 
persons with close relatives having diabetes, the 
obese, the elderly, pregnant females, and patients 
with arteriosclerosis, heart disease, and 
hypertension. The oral glucose tolerance test (OGTT) 
is the method used to determine the blood glucose 
levels after an overnight fast and at specified 
times following an oral glucose load. 
5 
3. GTF (Glucose tolerance factor) - GTF has been 
defined as a dietary component required for the 
maintainance of normal glucose tolerance. Trivalent 
chromium is considered as its active ingredient. 
4. Hypoglycemia - Low blood sugar; below normal levels 
(normal whole blood concentration= 70-90 mg/dl). 
5. Hyperglycemia - Elevated blood sugar; above normal 
level (normal whole blood concentration= 70-90 
mg/dl). 
6. Hypocholesterolemia - Low serum cholesterol; below 
normal level (normal serum concentration= 100~230 
mg/dl). 
7. Hypercholesterolemia - Elevated serum cholesterol 
level; above normal level (normal serum 
concentration= 100-230 mg/dl). 
6 
CHAPTER II 
REVIEW OF LITERATURE 
Chromium (Cr) can occur in every one of the oxidation 
states from -2 to +6, but only the ground state o, +2, +3, 
and +6 are common. The trivalent is the most stable valence 
state of chromium. It has a strong tendency to form 
coordination compounds, complexes, and chelates. Chromium 
complexes have a slow rate of ligand exchange. 
Chromium is an essential nutrient that functions in 
carbohydrate, lipid and nucleic acid metabolism. 
Insufficient dietary Cr intake leads to signs and symptoms 
similar to those associated with maturity-onset diabetes and 
cardiovascular disease (Borel and Anderson 1984). 
Chromium and Glucose 
In 1957, Schwarz and Mertz (1957) observed impaired 
glucose tolerance in rats fed certain diets and postulated 
that the condition was due to a deficiency of a new dietary 
agent, designated the glucose tolerance factor (GTF). 
Chromium affected glucose tolerance by potentiating insulin 
activity. Much higher amounts of insulin were required when 
Cr levels were very low both in vivo and in vitro. overall 
glucose breakdown can be increased by increasing insulin 
7 
! 8 
I 
c1ncentration but also by adding biologically active Cr and 
keeping the total amount of insulin constant (Anderson et 
al. 1978). Because high levels of insulin were associated 
with cardiovascular disease as secondary symptoms in 
diabetes (Stout 1977), keeping circulating insulin normal is 
a lgood way to reduce cardiovascular damage in diabetes. 
chromium potentiated the insulin activity with less insulin 
requirement. 
The clinical reports (Jeejeebhoy et al. 1977, Freund et 
al. 1979, Brown et al. 1986) support the effect of chromium 
ori insulin potentiation. A female patient had been on TPN 
for three years and had severe diabetic-like symptoms 
including glucose intolerance, inability to utilize glucose 
for energy, neuropathy, high fatty acid levels, low 
respiratory quotient and abnormalities of nitrogen 
m~tabolism. Supplementation of 250 ug daily of Cr as 
i 
criromium chloride changed intravenous glucose tolerance and 
respiratory quotient to normal. All the symptoms disappeared 
after a daily maintenance dose of 20 ug (Jeejeebhoy et al. 
1977). Similar results were observed in a second patient 
receiving total parenteral nutrition (Freund et al. 1979). 
Iri a third case, a sixty-three year old female developed 
i 
utjexplained hyperglycemia and glycosuria during total 
p~renteral nutrition thearapy. After fourteen days of 
supplemental intravenous chromium chloride (200 ug/day), the 
patient had no more hyperglycemia and glycosuria and did not 
r~quire exogenous insulin (Brown et al. 1986). 
I 
Chromium supplementation affected not only TPN patients 
but also others. Children with protein-calorie malnutrition, 
the elderly, insulin and non-insulin dependent diabetics, 
hypoglycemic subjects and subjects of varying ages with 
marginally impaired glucose tolerance have all responded to 
ctjromium supplementation. 
i 
Malnourished children with low-chromium diets responded 
to chromium supplementation. The glucose removal rates of 
Jordanian infants were·improved from 0.6 to 2.9%/min and 
those of the Nigerian infants were improved from 1.2 to 2.9 
%/min following Cr supplementation. The infants from each 
area without Cr supplementation had no significant changes 
in glucose removal rates (Hopkins et al. 1968). 
However, the glucose tolerance of malnourished children 
from Egypt was not improved following Cr supplementation. 
The dietary Cr intake of those children was higher than that 
of the children whose glucose tolerance improved following 
supplemental Cr (Carter et al. 1968). This suggests that 
chromium supplementation only benefited the subjects who had 
chromium deficiency. 
Glucose removal rates of 9 of 14 Turkish children with 
marasmic protein-calorie malnutrition also improved within 
18 h of oral administration of 250 ug of Cr as crc13 .6H2o. 
There was no change in the control group (5 children) 
(Gurson and Saner 1971). There was a significant increase in 
growth in those children who responded to Cr 
supplementation. 
9 
Many studies have reported beneficial effects of er on 
subjects with various degrees of glucose intolerance 
(Glinsmann and Mertz 1966, Levine et al. 1968, Hopkins et 
al. 1968, Gurson and Saner 1971, Nath et al. 1979; Anderson 
et al. 1983, 1984, Mossop 1983). Supplemental Cr also 
improved the glucose tolerance of elderly subjects, 
maturity-onset diabetics and insulin-requiring diabetics. 
Glinsmann and Mertz (1966) found that 150-1000 ug of 
inorganic Cr/day for 2-17 wk improved oral glucose tolerance 
in 3 of 6 noninsulin-dependent diabetics (Glinsmann and 
Mertz 1966). Levine et al. (1968) reported that 4 of 10 
elderly subjects with abnormal glucose tolerance normalized 
after treatment with 150 ug Cr/day for 3-4 months. Nath et 
al. (1979) and Mossop (Mossop 1983) also studied the effects 
of supplemental Cr in maturity-onset diabetics. Both studies 
reported beneficial effects of supplemental Cr on glucose 
and insulin parameters. The study by Mossop (1983) was a 
double-blind design. Twenty-six diabetics treated with 
either oral therapy or insulin were divided into two groups. 
Thirteen subjects received 600 ug chromium chloride daily 
and 13 received placebo for 2-4 months. Mean fasting blood 
glucose of diabetics receiving Cr decreased from 259 to 119 
mg/dl and level of oral therapy or insulin treatment 
decreased in 5 of the 13 subjects. Mean fasting glucose 
levels of the 13 diabetics on placebo reduced slightly from 
259 to 221 mg/dl but this decrease was probably due to the 
fact that treatment for diabetes was increased in 4 of the 
10 
i 
1~ patients. High-density lipoprotein cholesterol (HDL) 
I 
• I increased nearly 17 mg/dl in the group receiving Cr and 
decreased more than 6 mg/dl in the placebo group (Mossop 
1983). 
Anderson et al. (1983) reported that 76 normal subjects 
wire given Cr (200 ug Cr/day in the form of chromic 
chloride) or placebo in a double-blind crossover study with 
3 month experimental periods. The serum glucose of the 
subjects with marginally impaired glucose tolerance was 
decreased significantly following er supplementation. In 
China, 63 noninsulin-dependent diabetic patients were given 
high-Cr yeast (100 ug Cr/day), low-er yeast, or placebo 
(Cheng et al. 1987). After two months, the fasting blood 
glucose was decreased and glucose tolerance was improved 
significantly in the high-Cr yeast group but not in the low-
er yeast or placebo groups (Cheng et al. 1987). 
Anderson and co-workers (1991) investigated glucose 
tolerance of 11 female and 6 male subjects whose 
low-chromium diets contained chromium in the lowest quartile 
of normal intake in a 14 wk study. Subjects were divided 
into hyperglycemic and control group with a double-blind 
study design. The results showed that glucose tolerance and 
circulating insulin and glucagon of the hyperglycemic group 
all improved during chromium supplementation (200 ug/d) 
whereas those of the control group were unchanged. Glucose 
and insulin concentrations 60 min after the oral glucose 
challenge and the sum of the 0-90 min and 0-240 min glucose 
11 
i 
vqlues were all significantly lower after chromium 
I 
I 
supplementation in the hyperglycemic group. The study 
demonstrated that consumption of diets in the lowest 25% of 
normal chromium intake led to detrimental effects on glucose 
tolerance, insulin, and glucagon in subjects with mildly 
impaired glucose tolerance (Anderson et al. 1991). 
Chromium also showed effects on hypoglycemia. Eight 
female patients with symptoms of hypoglycemia were 
supplemented with 200 ug of Cr as chromic chloride for three 
months in a double-blind crossover experimental design study 
(Anderson et al. 1987). Chromium supplementation improved 
hypoglycemic symptoms and increased the minimum serum 
glucose values significantly two to four hours following a 
glucose load. Insulin binding to red blood cells and insulin 
receptor number also improved significantly during Cr 
supplementation. One study showed that chromium has growth 
stimulating effects on the endocrine pancreas (Hubner et al. 
1988). Wistar rats were given Cr (III) orally as chromium 
chloride for 8 weeks (15 ppm or 3 ppm/day) while consuming 
high (HFD) or low fat diets (LFD). In HFD animals (n = 12), 
chromium supplementation increased volume of islets (41%) 
compared to HFD controls. Many small islets were found which 
may be newly formed. In general polynesia and hyperplasia of 
' 
islets were observed. In LFD animals (n = 12), morphometric 
changes were not found but macronesia, micronesia and 
polynesia of islets were observed in the chromium 
supplemented group compared with the control group. 
12 
I 
I 
er. 
Some studies have reported no beneficial effects with 
Sherman and co-workers (1968) reported no effect of Cr 
supplementation (150 ug of trivalent chromium per day for 16 
weeks) in four normal subjects and ten diabetics. Uusitupa 
e~ al. supplemented 10 noninsulin-dependent diabetic 
p~tients with 200 ug trivalent chromium per day. There were 
I 
no significant differences in the serum glucose and lipids, 
except for a decrease in serum insulin (Uusitupa et al. 
1983). Rabinowitz et al. reported no significant change in 
glucose values of 43 diabetics following supplements of 
inorganic chromium and yeast for 12 months (Rabinowitz et 
al. 1983). 
Obviously, chromium deficiency was only one of the 
reasons for glucose intolerance. No matter what the results 
of supplemental er on glucose tolerance were, one thing to 
note is that chromium supplementation only benefits the 
' subjects who were marginally or clearly deficient in Cr. 
Chromium should be considered as a nutrient not as a 
therapeutic agent. 
Glucose Tolerance Factor (GTF) 
In 1957, Schwarz and Mertz proposed that glucose 
t9lerance factor (GTF) was required for the maintenance of 
' 
normal glucose tolerance in rats (Schwarz and Mertz 1957). 
GTF was extracted and concentrated from brewer's yeast and 
pork kidney powder and contained chromium as its active 
ingredient. Although the chemical structure of the 
13 
I 
I 
c1mpound(s) with GTF activity is not known, some of the 
biological properties have been detected (Mertz and Thurman 
1968). Mertz proposed that the structure responsible for the 
activity was a nicotinic acid-chromium-nicotinic acid axis 
with ligands of glutamic acid, glycine and cysteine (Mertz 
1~69, Mertz et al. 1974, Mertz 1974). The functions of GTF 
i 
included improvement of impaired intravenous glucose 
tolerance in vivo (Schwarz and Mertz 1959), enhancement of 
glucose metabolism in yeast (Mirsky et al. 1980) and a 
potentiating effect on the action of insulin on glucose 
metabolism in rat fat pads (Mertz et al. 1961). GTF 
pcitentiated the effects of insulin on glucose metabolism in 
epididymal fat tissue more than did simple chromium 
complexes. In vivo the impaired glucose tolerance of 
chromium-deficient rats can be improved by small amounts of 
chromium in the GTF form. So GTF, an organic chromium 
ccimplex, has strong effects on glucose metabolism of 
epididymal fat tissue quantitatively. 
GTF-like substances have been found in foods (Toepfer 
et al. 1973, Haylock et al. 1983), and animal tissues 
(Schwarz and Mertz 1959, Haylock et al. 1983). Yamamoto and 
h~s co-workers reported a biologically active, low-
mdlecular-weight, chromium-binding substance from milk 
I (~-LMCr) and rabbit liver which appeared to have GTF 
properties similar to yeast and the low-molecular-weight, 
chromium-binding substance present in mammalian liver 
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(Yamamoto et al. 1981, 1984, 1988). However, the chemical 
nature of GTF has not yet been established. 
Urberg and Zemel have studied the synergism between 
chromium and nicotinic acid in glucose metabolism (Urberg 
and Zemel 1987). Sixteen healthy elderly volunteers were 
divided into three groups and given 200 ug Cr, 100 mg 
nicotinic acid, or 200 ug Cr± 100 mg nicotinic acid daily 
for 28 days. The results showed that fasting glucose and 
glucose tolerance were affected neither by chromium nor by 
nicotinic acid alone. The combination Cr-nicotinic acid 
supplement caused a 15% decrease in a glucose area 
integrated total (P < 0.025) and a 7% decrease in fasting 
glucose. 
Fischer and co-workers reported that cationic samples 
with low molecular weight were obtained by partial 
purification from yeast extract. These samples increased the 
rate of glucose transport in isolated cardiomyocytes 2.0 -
2.5 fold. A further purification by gel filtration suggested 
that L-alanine might be involved in the regulation of 
glucose transport in cardiomyocytes (Fischer et al. 1992). 
Khan and co-workers found an unidentified factor that 
potentiates the function of insulin in selected foods and 
spices. They also found that insulin potentiating activity 
of these foods and spices did not correlate with total 
chromium (Khan et al. 1990). 
Simonoff and co-workers reported that individual 
fractions with GTF activity did not differ between Cr-rich 
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and Cr-deficient yeast, and there was also no relationship 
i 
between Cr concentration and GTF activity. This study does 
not support the hypothesis that chromium is an obligatory 
constituent of GTF, assuming that GTF is a unique substance 
(Simonoff et al. 1992). Further study of organic Cr 
complexes is needed to resolve these inconsistencies. 
Chromium and Lipid 
Marginal Cr intake has been related to abnormal lipid 
metabolism and ultimately atherosclerosis in both animal and 
h4JD.an studies. Rats fed a low Cr diet increased serum 
cholesterol, aortic lipids and plaque formation with 
increasing age (Schroeder and Balassa 1965). In rabbits 
atherosclerotic plaques were induced by feeding a 
high-cholesterol diet (standard diet with 1.5% cholesterol 
added). After intraperitoneal administration of Cr (20 ug 
! 
potassium chromate per day} for 60 days, the size of aortic 
plaques and aortic cholesterol concentration were decreased 
(Abraham et al. 1980). Eight rabbits fed a 1% cholesterol 
diet for 30 days were injected daily with potasium chromate 
for 60 days. A 50% reduction in aortic intimal plaque area 
and in aortic total cholesterol concentration was observed. 
Six rabbits were injected with potassium chromate and fed a 
1% cholesterol diet for 12 weeks. Mean aortic cholesterol 
concentration was significantly lower than the control group 
and the area of aortic intima covered by macroscopic plaques 
was smaller than the control group (Abraham et al. 1982). A 
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r~cent study from Abraham and co-workers investigated the 
effects of Cr on atherosclerosis in rabbits again (Abraham 
et al. 1991). Thirty-three rabbits fed a 
hypercholesterolemic diet were randomized into 6 groups and 
treated with daily injection of either water, 10 or 20 ug of 
potassium chromate or 1, 5, 10 or 20 ug of chromium 
I 
chloride, respectively for 135 days. The percentage of 
aortic intimal surface covered by plaque was reduced in the 
treated animals. Rabbits treated with 20 ug of chromium 
chloride showed a better response than those treated with 
either 10 or 20 ug of potassium chromate. 
An early study reported that individuals who died of 
coronary artery disease had lower Cr concentration in aortic 
tissue compared to subjects dying from accidents, even 
through the Cr concentration of other tissues analyzed was 
similar (Schroeder et al. 1970). The concentration of serum 
chromium in the subjects with coronary artery disease was 
lower than in the subjects without symptoms of disease 
(Newman et al. 1978). In that study low serum Cr and high 
serum triglyceride were highly correlated (p < 0.01 and 
p < 0.05 respectively) with the appearance of coronary 
artery disease whereas there was no correlation between 
other risk factors. 
Chromium was given to 12 adult men (200 ug Cr as 
chromium chloride daily). After 12 weeks. serum triglyceride 
concentrations decreased significantly and the 
co.ncentrations of high-density lipoprotein cholesterol 
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inbreased significantly compared to the subjects given 
placebo (Riales and Albrink 1981). Chromium supplementation 
(600 ug Cr as chromium chloride daily) of diabetic patients 
significantly increased the high density lipoprotein 
ch·olesterol and increased the total cholesterol (Mossop 
1983} •. In China, high-chromium yeast was supplemented to 
nineteen hypertriglyceridemic subjects (200 ug Cr/day). 
After two months the concentrations of serum triglyceride 
were decreased significantly in the Cr-supplemented group, 
but there was no change in the control group (Jiang et al. 
1990). Also many studies have reported beneficial effects on 
serum lipids following supplementation with brewer's yeast 
that was high in Cr (Borel and Anderson 1984). 
Twenty-eight subjects were given either chromium 
tripicolinate (200 ug Cr) or a placebo daily for 42 days in 
a double-blind crossover study. The results showed that 
levels of total cholesterol, LDL, and apolipoprotein B (the 
principal protein of the LDL fraction) were decreased 
significantly in the chromium picolinate supplemented group. 
The concentration of apolipoprotein A-1 (the principal 
protein of the HDL fraction) was increased substantially 
during chromium picolinate supplementation. These results 
showed that chromium picolinate has hypolipide~ic effects in 
humans (Press et al. 1990). 
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Chromium and Nucleic Acids 
Before the interaction of chromium with insulin was 
identified, the relationship between chromium and nucleic 
acids was suggested by the observation that treatment of 
tissues with chromates and dichromates reduced the amount of 
n~cleic acid that could be extracted with trichloroacetic 
acid (Herrmann and Speck 1954). The effects were presented 
by reduction of the hexavalent to the trivalent form of Cr 
and formation of a Cr(III} complex with nucleic acids. 
Later, Wacker and Vallee (1959) investigated the 
concentrations and potential functions of several transition 
metals in nucleic acid preparations. They found that 
chromium bound to nucleic acids more tightly than other 
metals and was not removed by repeated treatments with 
ethylenediamine tetraacetic acid (EDTA). The concentrations 
of chromium were between 260 and 1080 ug/g in a beef liver 
nucleoprotein fraction. More pure preparations of RNA and 
DNA were found to contain from 18 to 400 ug Cr/g, depending 
on source and the mode of extraction. They also found that 
chromium stabilized the tertiary structures of nucleic acids 
by demonstrating a reduction of heat-induced changes of 
optical density in vitro. We have checked the chromium 
concentration of the hepatic nucleic acids in rats (5 ± 1 
ug/g dry weight} and found them lower than those reported 
earlier (Cheng et al. 1990a} . 
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Recently, more studies have been done because the 
interaction of chromates with nucleic acids was related to 
carcinogenicity in industrially exposed workers. The role of 
trivalent chromium as a physiological component in the 
metabolism of nucleic acids and in protein synthesis is also 
b~ing studied. Tamino et al. have reported that Cr(III) 
binds to mammalian DNA and RNA in vitro (Tamino et al. 
1981). Okada and collaborators reported that in vitro RNA 
synthesis directed by free DNA was significantly enhanced 
when Cr(III) was bound to the template (Okada et al. 1981a). 
The increase of RNA synthesis with Cr(III)-bound DNA is 
proportional to the molar binding ratio of Cr(III) to DNA. 
This enhancement possibly was caused by an increase in the 
number of initiation sites on DNA (Okada et al. 1982). In an 
in vitro system, Cr(III) bound to DNA preferentially in 
chromatin and increased the number of initiation sites (Ohba 
et al. 1986) which enhanced RNA synthesis. Okada et al. also 
reported that chromium was present in regenerating rat liver 
in vivo in the form of a chromium-protein of approximately 
70,000 daltons containing between 4 and 5 atoms of chromium, 
corresponding to approximately 3,600 ug chromium/g protein 
(Okada et al. 1984). In our study hepatic DNA of the 
Cr-depleted groups was significantly lower than the 
Cr-supplemented animals and hepatic RNA was similarly 
reduced by Cr depletion (Cheng et al. 1990b). 
Wolf et al. examined the interaction of chromium (III) 
and chromium (VI) with the phosphate groups of di- and 
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I. t 1iphosphate 
fcirmation of 
nucleotides by 31p-NMR spectroscopy. The 
Cr-nucleotide complexes could only be detected 
with Cr(III) through the chemical shifts of the phosphate 
groups (Wolf et al. 1989). 
Chromium has not been studied enough in this expanding 
f~eld of nucleic acid metabolism and the regulation of 
protein synthesis. This area should be considered one of the 
most promising for further research on the biological role 
of chromium. 
Copper and Lipid 
Copper, like chromium, is also involved in lipid 
metabolism. Klevay (1973) first found that copper deficiency 
increases serum cholesterol in rats which relates to Zn:cu 
ratio. Because a high level of dietary zinc increases copper 
deficiency, dietary zinc:copper ratio is considered as an 
important factor in hypercholesterolemia. Lei (1978) also 
showed hypercholesterolemia in copper deficient rats. Allen 
and Klevay (1978a) investigated the relationship between 
liver cholesterol and plasma chlesterol by injecting 
3ff-mevalonate into copper-deficient and control rats. The 
results suggested that copper deficiency causes rapid 
cholesterol release from the liver to plasma. The 
hyperlipidemic results were observed in rats with varied 
copper intake and feeding period (Petering et al. 1977, 
Allen and Klevay 1978a, 1978b, 1978c, Lau and Klevay 1981, 
1982, Katya-Katya et al. 1984, Looney and Lei 1978). Copper 
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al!so is an essential component of several enzymes includ"ing 
the CU-Zn form of the antioxidant enzyme superoxidase 
(F.ridovich 1975). Superoxide dismutase (SOD) is an important 
copper metalloenzyme that protects lipid cell membrane 
structures from oxidation by free oxygen radicals (McCord 
anp Fridovich 1969, Johnston and De Chatelet 1974). Animal 
I 
studies have shown that SOD activity in chicks (Bettger et 
al. 1979), pigs (Williams et al. 1976), and rats (Paynter et 
al. 1979) is related to copper nutrition. Therefore SOD 
activity can be considered as a potential index of copper 
nu~ritional status. 
I 
The Hypocholesterolemic Effect of a 
Chinese Herb (CH) in Animals 
A Chinese herb (CH) has been used for centuries as an 
important medicine and nutrient in the attempt to prevent 
aging in China. There have been several studies of CH in 
animals, but still very little is known of its physiological 
and chemical properties. 
The relationship between cholesterol and CH was 
investigated by Guo and Song in 1986. Eighty pigeons 
including males and females, mean body weight 300 g, were 
fed a hypercholesterolemic diet and were divided into three 
groups: CH supplemented (2g/day) group (n = 20), nicotinic 
acid supplemented (100 mg/day) group (n = 20), and the 
control group (n = 40). After 2 months, all pigeons were 
killed except 24 of the control group. These 24 pigeons were 
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divided into two groups again as CH supplemented and control 
groups for one more month. The results showed that mean 
serum cholesterol of both CH and nicotinic acid supplemented 
groups were significantly decreased (P < 0.001) compared 
with the control group. In the continued study of the 24 
pireons, serum cholesterol was significantly decreased 
(P < 0.025) by CH supplementation compared to the control 
group. This study showed the hypocholesterolemic effect of 
CH supplementation in pigeons fed a hypercholesterolemic 
diet (Guo and Song 1986). 
There was another study of effects of CH on 
cholesterol, related enzymes, and pathological observations 
in rats (Niau et al. 1988). Thirty-nine male rats, 135-145 
g, were divided into four groups and fed the following 
diets: normal diet (n = 9), hypercholesterolemic diet 
(2% cholesterol and 0.5% cholic acid) (n = 9), 
hypercholesterolemic diet with an extract from CH (n = 10), 
and hypercholesterolemic diet with CH powder (n = 11). After 
17 days, serum cholesterol levels in both the CH extract and 
the CH powder group were decreased significantly (P < 0.05) 
compared to the group fed the hypercholesterolemic diet 
alone. The hepatic ATPase and SDH (succinate dehydrogenase) 
in both CH supplemented groups were lower than in the 
control group. The hepatic G-6-P (glucose-6-phosphate) in 
the CH powder supplemented group was lower than the other 
groups. There were many neutral fat drops in the lobules of 
the liver in the group fed the hypercholesterolemic diet. 
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Both CH supplemented groups had very few fat drops and were 
' 
almost like the normal diet group. The results suggested 
that CH can be considered as a hypolipidemic agent. 
More lipidemic indices and atherosclerotic changes have 
been investigated in the Japanese quail (Wang and Jin 1984). 
Forty-six Japanese quail were divided into four groups. 
I 
These groups were supplemented with water (control) or with 
small (0.084 g/kg/day) (n = 10), medium (0.84 g/kg/day), or 
large doses (8.4 g/kg/day) (10) of CH extract with 
hypercholesterolemic diets (1% cholesterol). The results 
sh9wed that plasma HDL-cholesterol levels of the three 
CH~supplemented groups were increased compared to the 
control group. The HDL-cholesterol/total cholesterol ratios 
in the three CH-supplemented groups were increased after 2-5 
weeks. Plasma cholesterol and cholesterol esters in the 
three CH-supplemented groups were decreased compared to the 
control group after 6 weeks. Plasma triglyceride levels were 
decreased compared to the control group. Atherosclerotic 
changes in the aorta with the three levels of CH 
supplementation were less than in the control group, 
especially in the supplementation group with the large dose 
of CH. This study showed that CH had hypolipidemic effects 
and reduced atherosclerosis in Japanese quail. 
In another study, the conversion of cholesterol and 
cholic acid in vitro was observed in liver with 
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(7~3H)-cholesterol and three levels of CH. The result showed 
that the lowest concentration was the best for stimulating 
conversion of cholesterol to cholic acid (Xu and Li 1987). 
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CHAPTER III 
METHODOLOGY 
Study 1 (Chapter 4): The Effects of Chromium 
and a Chinese Herb on Serum Glucose 
and Cholesterol in Mice 
As:say of Insulin Potentiating Activity (IPA) of 24 Chinese 
herbs: 
Twenty-four Chinese herbs were separately stirred with 
a 20-fold excess (w/v) of 0.1 N NH40H for 2 hours and then 
centrifuged at 1,000 x g for 20 minutes. Insulin 
po~entiating activity of supernatant in each Chinese herb 
was evaluated using isolated adipocytes from epididymal fat 
tissue (Anderson et al. 1978) (see Appendix A). 
Animals and diets: 
Forty-two male weanling mice were randomly assigned to 
four groups: Cr-depletion group; Cr-depletion and Chinese 
herb-supplementation group; Cr-supplementation group (2 ppm 
Cr: as crcl3); and Cr- and Chinese herb-supplementation 
i 
grbup. 
I 
The diet contained: 20% Casein (U. s. Biochemical); 
0.3% DL Methionine (U. s. Biochemical); 65.0% Sucrose (Food 
Club); 5.0% Cellulose (Celufil); 5.0% corn oil (Wesson); 
26 
3. 15% AIN mineral mix without Cr; 1.0% AIN vitamin 
I 
choline bitartrate. 
mix; 0.2% 
Chinese herb (#13, i.e. CH)) was stirred with a 20-fold 
excess (w/v) of 0.1 N NH40H for 2 hours and then centrifuged 
at 1,000 x g for 20 minutes. Then the supernatant was 
adjusted to pH 7. Each mouse was given a daily oral dose of 
I 
I 
the CH or water as a placebo by micropipette. During the 
first 10 days, 25 ul per day was given; during the next 10 
days, 50 uL per day; then 100 uL per day was given until the 
end of the experiment. 
The mice were maintained on a 12-hr light dark cycle 
and had access to diet and deionized water ad libitum. Trace 
metal contamination was reduced by use of plastic housing 
and feeding equipment. 
After 6 weeks, mice were fasted 14 hr and then were 
given an oral glucose load (1 mg glucose /g body weight of a 
50% solution) 90 min before decapitation and blood 
collection. Tissues were weighed and serum was prepared and 
frozen. 
Serum glucose was analyzed by the glucose oxidase 
method using a glucose analyzer (Beckman Instruments, Inc., 
Fullerton, CA). Serum insulin was determined by 
radioimmunoassay (Pharmacia Diagnostics, Piscataway, NJ) and 
serum cholesterol was determined enzymatically (Sigma 
Chemical Co., st. Louis, MO). 
The experimental design was a 2 x 2 factorial with 
chromium and CH as factors. Data were evaluated by analysis 
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of variance. 
l 
study 2 (Chapter 5): The Effects of a Chinese 
Herb and Copper on Plasma Lipids in Mice 
Fed a Hypercholesterolemic Diet 
Extraction of Chinese herb (CH)): 
CH was stirred with a 20-fold excess (w/v) of 0.1 N 
NH40H for 2 hours and then centrifuged at. 1,000 g for 20 
minutes. Then the supernatant was adjusted to pH 7. 
Animals: 
Thirty male weanling mice were randomly assigned to 
four groups. The four groups are: Low-cu diet, Chinese herb 
supplemented group (Lowcu+CH), Low-cu diet without Chinese 
herb group (LowCU-CH), Adequate-CU diet, Chinese herb 
supplemented group (AdeqCu+CH), and Adequate-CU without 
Chinese herb (AdeqCU-CH). 
The mice were maintained on a 12-h light-dark cycle and 
had access to diet and deionized water ad libitum. Trace 
metal contamination was reduced by use of plastic housing 
and feeding equipment. 
Diets: 
The diet contained 20% casein, 0.3% DL-methionine, 
48j.5% sucrose, 5% cellulose (Celufil), 5% corn oil (Mazola), 
3.5% AIN mineral mix or 3.5% modified AIN mineral mix, 1.0% 
AIN vitamin mix, 0.2% choline bitartrate, 1.0% cholesterol, 
and 0.5% cholic acid. Using the AIN mineral mix added 7 mg 
Cu as cupric carbonate/kg diet while the modified mineral 
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mix added 0.7 mg Cu/kg diet. Each mouse was given 100 uL 
I 
oral dose of Chinese herb or water as a placebo by 
micropipette daily. 
After 12 weeks, mice were anesthetized and 
exsanguinated by heart puncture. Tissues were weighed and 
plasma was prepared and frozen. Plasma glucose and 
i 
cholesterol were analyzed using enzymatic methods. 
Triglycerides also were determined enzymatically. Red cell 
superoxide dismutase (SOD) was analyzed using the method of 
Roth and Gilbert (Roth and Gilber 1984). 
Study 3 (Chapter 6): The Effects of Fractions 
from a Chinese Herb on Plasma Glucose 
and Cholesterol in Mice Fed a 
Hypercholesterolemic Diet 
Fractionation of Chinese herb: 
CH was extracted with 0.1 N NH40H (1:20) and 
centrifuged (1,000 x g). The supernatant was applied to a 
Sephadex G-25 column (50-150 u of particle size, 60 x 2.6 
cm). Three fractions were collected and evaporated at room 
temperature to 1/3 of their original volume for experiment 1 
and to 1/10 of their original volume for experiment 2. Each 
combination of fractions was mixed from the specified 
fractions and equal concentrations were made. Each mouse was 
given 100 ul of Chinese herb or water orally by micropipette 
daily. 
Animals: 
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Experiment 1: Thirty-nine male weanling mice were 
randomly assigned to four groups. The four groups were: 
fraction 1, fraction 2, fraction 3, or control group. 
Experiment 2: Sixty-one male weanling mice were 
randomly assigned to six groups: fraction 1 & 2, fraction 1 
& 3, fraction 2 & 3, fraction 1 & 2 & 3, crude extraction, 
! 
I 
or· control. 
Diets and housing: 
The diet contained 20% casein, 0.3% DL-methionine, 
48. 5% sucrose, 5% cellu.lose (Celufil) , 5% corn oil (Mazola), 
3.5% AIN mineral mix or 3.5% modified AIN mineral mix, 1.0% 
AIN vitamin mix, 0.2% choline bitartrate, 1.0% cholesterol, 
and 0.5% cholic acid. 
All the mice were maintained on a 12-h light-dark cycle 
and had access to diet and deionized water ad libitum. Trace 
metal contamination was reduced by using of plastic housing 
and feeding equipment. 
Experiment 1 was finished after 10 weeks. Experiment 2 
was terminated after 9 weeks. Mice were anesthetized and 
exsanguinated by heart puncture. Tissues were weighed and 
plasma was prepared and frozen. Plasma glucose and 
cholesterol were analyzed using enzymatic methods. Insulin 
was analyzed by radioi:mmunoassay. 
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Study 4 (Chapter 7): The Effects of Fraction 1 
from a Chinese Herb on Plasma Glucose and 
Cholesterol in Obese Mice Fed a 
Hypercholesterolemic Diet 
Fractionation of Chinese herb (CH): 
CH was extracted with 0.1 N NH40H (1:20) and 
centrifuged (1,000 x g). The supernatant was applied to a 
Sephadex G-25 column (50-150 u of particle size). Three 
fractions were separated. The first fraction was collected 
and evaporated to 1/3 of its original volume at room 
temperature. 
Animals and diets. 
Nineteen male obese mice (51 days old) were randomly 
assigned to two groups: fraction 1 and control. The diet 
contained 20% casein, 0.3% DL-methionine, 48.5% sucrose, 5% 
cellulose (Celufil), 5% corn oil (Mazola), 3.5% AIN mineral 
mix or 3.5% modified AIN mineral mix, 1.0% AIN vitamin mix, 
0.2% choline bitartrate, 1.0% cholesterol, and 0.5% cholic 
acid. Each mouse was given 100 ul of fraction 1 of CH or 
water orally by micropipette daily. The mice were maintained 
on a 12-h light-dark cycle and had access to diet and 
deionized water ad libitum. Trace metal contamination was 
reduced by using plastic housing and feeding equipment. 
After 7 weeks, mice were fasted 14 hr and then were given an 
oral glucose load (1 mg/g body weight in a 50% solution) 60 
minutes before sacrifice. Mice were anesthetized and 
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e~sanguinated by heart puncture. Tissues were weighed and 
i plasma was prepared and frozen. 
Analysis: 
Plasma glucose and cholesterol were analyzed using 
enzymatic methods. Insulin was analyzed by radioimmunoassay. 
Study 5 (Chapter 8): Chromium Interaction with 
Nucleic Acids in Rat Liver 
Animals and materials: 
Male Sprague Dawley rats, 45-50 g, were divided into 
th[C'ee groups and feed either a low Cr diet, a low Cr diet 
I 
plus 1 ug Cr as chromium chloride per g of diet or a low Cr 
diet plus 100 ug of Cr per g of diet. Chromium concentration 
of the low Cr diet was approximately 30 ng/g. After eight to 
ten weeks, rats were sacrificed and livers were removed, 
rinsed, and stored on ice or frozen at -2ooc. Cold liver 
samples were homogenized with an equal weight of water and 
centrifuged (1000 x g). The supernatant was applied to a 
Sephadex G-15 column. RNA was determined by an orcinal 
method (Keleti and Lederer 1974), DNA by diphenylamine 
procedure (Keleti and Lederer 1974) and protein by the 
Biorad method (Bio-Rad Protein Assay Kit). Chromium was 
determined by atomic absorption spectroscopy as described 
I 
previously (Anderson and Kozlovsky 1985). 
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study 6 (Chapter 9): The Effects of Chromium 
Depletion on Hepatic Nucleic 
Acids in Guinea Pigs 
Animals and diets: 
Thirty-six guinea pigs (mean weight= 179 g) were 
di~ided into four groups: Cr and ascorbate-depletion group; 
Cr-depletion and ascorbate-supplementation group; 
er-supplementation and ascorbate-depletion group; and 
er- and ascorbate-supplementation group. 
The diet contained (g/kg): 370 dextrose, JOO casein, JO 
L-arginine HCl, 150 Celufil, 70 corn oil, 50 mineral mix, 35 
potassium acetate and 22 vitamin mix without ascorbate. The 
mineral mix contained (g/kg): 600 CaHP04 , 80 NaCl, 100 MgO, 
0.90 ZnC03, 1.8 MnC03, 0.25 CuC03, 3.5 KI03, 0.67 NaSe03, 
1.42 FeC12 and a quantity of sucrose sufficient to make 1 
kg. Diets contained< 60 ng/g chromium (-Cr) or were 
supplemented with 2 ug/g Cr as Crcl3 (+Cr). Animals were 
dosed orally with 1 mg ascorbate/day (-Cr) or with 10 mg/day 
(+Cr). 
Animals had diet and deionized water ad libitum. They 
were housed in plastic cages to reduce trace mineral 
contamination. 
Guinea pigs were weighed weekly. After 20 weeks, guinea 
pigs were anesthetized and exsanguinated by heart puncture. 
Liver was frozen immediately. Hepatic RNA and DNA were 
separated (Keleti and Lederer 1974) (see Appendix B). 
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Anllysis: 
I The experimental design was a 2 x 2 factorial with 
chromium and ascorbate as factors. Data were evaluated by 
analysis of variance. 
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CHAPTER IV 
THE EFFECTS OF CHROMIUM AND A CHINESE 
. HERB (CH) ON SERUM GLUCOSE AND 
CHOLESTEROL IN MICE 
Abstract 
A Chinese herb (CH), which had high IPA, was selected 
to feed mice. Forty-two male weanling mice were randomly 
grouped in a 2 x 2 factorial design. Groups were: -cr+CH, 
-er-CH, +Cr+CH, +er-CH. CH was extracted with 0.1 N NH40H 
(1:20). Each mouse was given an oral dose of CH or water by 
micropipette. After 6 weeks, neither CH nor Cr affected body 
weight gain. Chromium supplementation decreased liver weight 
(P < 0.02) and CH decreased spleen weight (P < 0.02). Serum 
glucose was not altered by treatment. Serum cholesterol 
concentrations were significantly decreased (P < 0.02) with 
CH supplementation. These data demonstrated that the Chinese 
herb, CH, had significant insulin-potentiating activity in 
vitro and reduced serum cholesterol in mice. 
INDEXING KEY WORDS: 
• chromium. insulin potentiating activity 
• Chinese herb. chromium chloride. cholesterol 
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Glucose intolerance is usually one of the first 
I 
measurable signs of er deficiency and also of diabetes. The 
early experiments of Schwarz and Mertz (Schwarz and Mertz 
1957, 1959) led to the discovery of Cr as an essential 
nutrient in preventing and reversing glucose intolerance. In 
these studies, supplementing the apparently low Cr diet of 
I 
rats with er led to rapid improvements in glucose tolerance. 
Chromium supplementation of patients on total parenteral 
nutrition also led to significant improvements in several 
diabetic-like symptoms including glucose intolerance 
i (J~ejeebhoy et al. 1977). Chromium also affects lipid 
I 
metabolism, such as serum cholesterol (Schroeder and 
Balassa, 1965, Abraham et al. 1982), and serum insulin (Nath 
et al. 1979, Mossop 1983, Anderson et al. 1984). Chromium 
functions in glucose tolerance primarily through its insulin 
potentiation (Anderson et al. 1978). 
There are several traditional medicines which have been 
used for diabetic-like symptoms in China for centuries, but 
their insulin-potentiating activity (IPA) has not been 
evaluated. In this study several of these Chinese herbs were 
assayed for IPA. A Chinese herb (CH) which had high IPA was 
selected to use in an animal study. The purpose of this 
stu~y was to investigate the effects of chromium and CH on 
I 
serum glucose and cholesterol in mice. 
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Materials and Methods 
Extraction of Chinese herbs and Assay of IPA. Chinese 
herbs were stirred with a 20-fold excess (w/v) of 0.1 N 
NH40H for 2 hr and then centrifuged at 1,000 x g for 20 min. 
The supernatant of each Chinese herb was assayed for insulin 
I 
potentiating activity (IPA) in the rat epididymal fat cell 
bioassay (Anderson et al. 1978) (see Appendix A). 
Animals and diets. Forty-two male weanling mice were 
randomly assigned to four groups: er-depletion group; 
Cr-depletion and CH-supplementation group; 
er-supplementation group (2 ppm Cr as crcl3); er- and 
CH-supplementation group. 
The diet contained: 20% casein (U. s. Biochemical); 
0.3% DL methionine (U. s. Biochemical); 65.0% sucrose (Food 
Club); 5.0% cellulose (Celufil); 5.0% corn oil (Wesson); 
3.5% AIN minerai mix without Cr; 1.0% AIN vitamin mix; 0.2% 
choline bitartrate. 
Each mouse was given a daily oral dose of CH or water 
as a placebo by micropipette. During the first 10 days, 25 
ul per day was fed. During the next 10 days, so uL per day 
was given. Then 100 uL per day of CH was given until the end 
of the experiment. 
The mice were maintained on a 12-hr light dark cycle 
and had access to diet and deionized water ad libitum. Trace 
metal contamination was reduced by use of plastic housing 
and feeding equipment. After 6 weeks, mice were fasted 14 hr 
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i 
anci then were given an oral glucose load (1 mg glucose/g 
I 
body weight in a 50% solution) 90 min before decapitation 
and blood collection. Tissues were weighed and serum was 
prepared and frozen. 
Analysis. Serum glucose was analyzed by the glucose 
oxidase method using a glucose analyzer (Kadish et al. 
i 
1968). Serum insulin was determined by radioimmunoassay 
(Crowley & Garbien 1974) and serum cholesterol was 
determined enzymatically (Allain et al. 1974). 
Statistics. The experimental design was a 2 x 2 
factorial with chromium and CH as factors. Data were 
evaluated by analysis of variance. 
Results and Discussion 
The insulin potentiating activity of Chinese herb #13 
(CH) was higher than all other Chinese herbs (Table 1). Thus 
' 
cHimight enhance glucose utilization. 
Neither CH nor Cr significantly affected body weight 
gain (Table 2). Chromium supplementation decreased liver 
weight significantly in this study (P < 0.02) (Table 2). 
Chromium functions by increasing the activity of insulin 
(Jeejeebhoy 1977, Freund 1979). Insulin plays the role of 
stimulation of lipogenesis and inhibition of lipolysis which 
might be an explaination for the increasing liver weight in 
the chromium-depletion animals. CH also changed spleen 
wei,ght in this study. We really don't know the mechanism for 
these results. Further study needs to be done. 
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Chromium supplementation did not affect blood glucose, 
I 
in~ulin and cholesterol compared to the chromium depletion 
group (Table 3). Flatt and his co-workers reported there 
were no effects on plasma glucose and insulin between 
Cr(III) supplemented mice (1 mg Cr/kg diet) and Cr (III) 
deficient mice (0.03 mg/kg) after 32 days (Flatt et al. 
I 
1989). Donaldson and coworkers reported that there were no 
significant differences in plasma glucose, cholesterol and 
triglyceride in rats fed either a low-chromium (60 to 100 
ug/kg of diet) or chromium- supplemented (5 mg/kg of diets) 
h~erglycemic and hyperlipidemic diets (Donaldson et al. 
1985). 
Some human studies also showed no effect of chromium 
supplementation. Sherman and coworkers (Sherman et al. 1968) 
reported no effect on glucose and lipids with chromium 
supplementation (150 ug of chromium as crcl3/day for 16 
we~ks) in four normal subjects and ten diabetics. Uusitupa 
et al. 1983) supplemented chromium (200 ug/day as crcl3) in 
10 noninsulin-dependent diabetic patients. There were no 
significant changes in serum glucose and lipids. Rabinowitz 
et .al. also reported no effect on glucose of forty-three 
· dia.betics fallowing supplements of inorganic chromium and 
cr-iyeast for 12 months (Rabinowitz et al. 1983). 
Chromium deficiency is considered as one of the reasons 
for glucose intolerance. But chromium supplementation only 
can benefit the subjects who have chromium deficient status. 
In an animal studies, making the er-depleted animal model is 
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the most important step to get effective results from Cr-
supplementation. From the results of this study, the mice 
might not have become Cr-depleted for some reasons, such as 
time, on the diet, or chromium content of the diet 
(Unfortunately we did not analyze the chromium content in 
this diet). 
With the high IPA in the crude extract of CH, an 
hypoglycemic effect was expected instead of a 
hypocholesterolemic effect. In this study, serum cholesterol 
concentrations were significantly decreased (P < 0.02) with 
CH:supplementation. The same results were reported in 
pigeons, rats and Japanese quail (Guo and Song 1986, Niou et 
al. 1988, Wang 1984). Our study confirmed the 
hypocholesterolemic effect of CH. But little is known about 
their biological and chemical properties. So further study 
is needed. These data demonstrate that the Chinese herb {CH) 
has high insulin-potentiating activity in vitro and a 
hypocholesterolemic effect in mice. 
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TABLE 1 
INSULIN POTENTIATION OF CHINESE HERBS 
--~--------------------------------------------------------Samples 
Standard Yeast #1 
standard Yeast #2 
No.1 
No.2 
No.3 
No.4 
No~S 
No~6 
No.7 
No.a 
No.9 
No.10 
No.11 
No.12 
No.13 (CH) 
No.14 
No.15 
No~16 
No~17 
No.18 
No.19 
No.20 
No.21 
No.22 
No.23 
No.24 
Insulin Potentiation 
2.9 
1.7 
0.9 
1.1 
0.6 
o.s 
1.5 
1.1 
1.0 
1.1 
1.3 
0.8 
1.2 
2.1 
4.1 
0.9 
1.2 
1.3 
1.2 
1.2 
1.2 
1.2 
1.3 
1.0 
1.1 
1.1 
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TABLE 2 
WEIGHT GAIN AND TISSUE WEIGHTS OF MICE 
FED EXPERIMENTAL DIETsl 
-----------------------------------------------------------Group Wt Gain Liver Spleen 
(g) (g) (g) 
-----------------------------------------------------------
-er + CH 
-er - CH 
'1 
+er + CH 
+Cr 
- CH 
Source of 
Vai;:-iation 
Cr' 
CH 
Cr*CH 
14.2 ± 
14.9 ± 
14.1 ± 
13.8 ± 
0.18 
0.67 
0.29 
0.3 
0.5 
0.5 
0.5 
1. Mean+ SEM, n=9-11. 
1.04 ± 0.03 
1.09 ± 0.03 
1.00 ± 0.03 
1.01 ± 0.02 
Analysis of Variance 
P Value 
0.19 
0.55 
2. Significant difference. 
0.06 
0.07 
0.06 
0.07 
± 0.002 
± 0.004 
± 0.002 
± 0.004 
0.68 
0.022 
0.21 
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TABLE 3 
SERUM CONCENTRATION OF INSULIN, GLUCOSE 
AND CHOLESTEROL! 
-----------------------------------------------------------Group Insulin Glucose Cholesterol 
(uU/ml) (mg/dl) (mg/dl) 
-----------------------------------------------------------
-er + CH 
-er - CH 
i 
+er + CH 
+Cr 
-
CH 
Source of 
Variation 
Cr: 
CH 
Cr*CH 
8.0 
9.0 
7.7 
7.1 
± 0.6 
± 1.0 
± 0.7 
± 0.5 
0.13 
0.77 
0.31 
1. Mean± SEM, n=7-11. 
2. Significant difference. 
147 ± 9.8 
153 ± 7.7 
140 ± 8.0 
156 ± 10.7 
Analysis of Variance 
P Value 
0.84 
0.22 
0.63 
94 
116 
112 
124 
± 5 
± 7 
± 6 
± 8 
0.07 
0.022 
0.52 
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CHAPTER V 
THE EFFECTS OF A CHINESE HERB AND COPPER 
ON PLASMA LIPID IN MICE FED A 
HYPERCHOLESTEROLEMIC DIET 
Abstract 
The purpose of this study was to investigate the 
effects of a Chinese herb (CH) with high insulin 
potentiating activity and two levels of dietary copper in 
mice fed a casein-based hypercholesterolemic diet containing 
1.0% cholesterol and 0.5% cholic acid. Diets were 
supplemented with 0.7 (LowCu) or 7.0 (AdeqCu) ug/g copper as 
cupric carbonate. Thirty male weanling mice were grouped in 
a 2 x 2 factorial design. Groups were: Lowcu-CH, Adeqcu-CH, 
Lowcu+CH, and AdeqCU+CH. The Chinese herb was extracted with 
0.1 N NH40H (1:20) and then adjusted to pH 7.0. Mice were 
fed daily with 100 uL of CH extract by micropipette. After 
12 wk of treatment, body and tissue weights, plasma glucose 
and triglycerides, and erythrocyte superoxide dismutase 
(SOD) activity were not significantly affected by either CH 
or cu. Mean plasma cholesterol was 191 mg/dl for the -CH 
groups and 171 mg/dL for +CH groups (p < 0.04). These 
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results demonstrated the hypocholesterolemic effect of CH in 
mice fed a hypercholesterolemic diet. 
INDEXING KEY WORDS: 
.chromium .Chinese herb .glucose .cholesterol 
.insulin potentiating activity .superoxide dismutase (SOD) 
Various traditional Chinese herbs have been used for 
treatment of diabetes and hyperlipidemia in China, but 
little is known about their biological and physiological 
functions. One Chinese herb (CH) consistently had high 
insulin potentiating activity and had a hypocholesterolemic 
effect in our preliminary animal study (Cheng et al. 1988). 
In an initial experiment, high ratios of zinc to copper 
produced hypercholesterolemia in rats (Klevay 1973). 
Other experiments have shown hypercholesterolemia in copper 
deficiency (Allen and Klevay 1978a, 1978b, 1978c, Lei 1978). 
Different copper intakes and feeding periods influenced the 
hyperlipidemic result in rats (Petering et al. 1977, Allen 
and Klevay 1978a, 1978b, 1978c, Lau and Klevay 1981, 1982, 
Katya-Katya et al. 1984, Looney and Lei 1981). Copper also 
is an essential component of several enzymes (Fridovich 
1975) including superoxide dismutase (SOD). According to 
animal studies (Bettger et al. 1979, Williams et al. 1976, 
Paynter et al. 1979), SOD activity can be considered as a 
potential index of copper nutritional status. 
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Because copper has been implicated as a micronutrient 
affecting cholesterol metabolism, both copper and Chinese 
herbs were selected as variables in a 2 X 2 factorial 
experiment. The purpose of this study was to investigate the 
effect of the Chinese herb and two levels of copper in mice 
fed a hypercholesterolemic diet. 
Materials and Methods 
Animals. Thirty male weanling mice were randomly 
assigned to four groups. The four groups were: Low cu diet 
supplemented with Chinese herb (Lowcu+CH), Low Cu diet 
without Chinese herb (Lowcu-CH), Adequate-cu diet 
supplemented with Chinese herb (Adeqcu+CH), and Adequate cu 
without Chinese herb (AdqeqCU-CH). 
The mice were maintained on a 12-h light-dark cycle and 
had access to diet and deionized water ad libitum. Trace 
metal contamination was reduced by use of plastic housing 
and feeding equipment. 
Diets. The diet contained 20% casein, 0.3% 
DL-methionine, 48.5% sucrose, 5% cellulose (Celufil), 5% 
corn oil (Mazola), 3.5% AIN mineral mix or 3.5% modified AIN 
mineral mix, 1.0% AIN vitamin mix, 0.2% choline bitartrate, 
1.0% cholesterol, and 0.5% cholic acid. Using the AIN 
mineral mix added 7 mg Cu as cupric carbonate/kg diet while 
the modified mineral mix added 0.7 mg Cu/kg diet. CH was 
extracted with 0.1 N NH40H (1:20) and then adjusted to pH 
7.0. Each mouse was given a 100 uL oral dose of CH or water 
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as a placebo by micropipette daily. After 12 weeks, mice 
were anesthetized and exsanguinated by heart puncture. 
Tissues were weighed and plasma was prepared and frozen. 
Analysis. Plasma glucose and cholesterol were analyzed 
using enzymatic methods (Method #510 and Method #352, Sigma 
Chemical Co., st Louis, MO). Triglycerides also were 
' I 
determined enzymatically (Seragen Diagnostics, Indianapolis, 
IN). Erythrocyte SOD was analyzed using the method of Roth 
and Gilbert (Roth and Gilbert 1984). 
Statistics. The experimental design was a 2 X 2 
factorial with CH and cu as factors. Data were evaluated by 
I 
analysis of variance. 
Results and Discussion 
After 12 weeks, body and tissue weights (Table 1), 
plasma glucose and triglycerides, and erythrocyte superoxide 
diJmutase (SOD) activity (Table 2) were not significantly 
different among groups. The plasma cholesterol concentration 
(Table 2) was significantly reduced by CH supplementation 
(P < 0.04). The reduction of plasma cholesterol by CH in 
this study confirmed the hypocholesterolemic effect of this 
Chinese herb in different animals (Guo and song 1986, Niou 
et !al 1988, Wang and Jin 1984). 
In this study, the copper concentration in diet did not 
affect the plasma cholesterol (Table 2). Several studies 
(Fischer et al. 1980, Caster & Doster 1979, Geiger et al. 
1984, Hunsaker et al. 1984, Lin & Lei 1981, Sherman 1981) 
showed no effect on cholesterol at various copper intakes 
and with different Zn/CU ratios. Dietary interactions may 
influence the copper effect, such as source of protein (Cohn 
et al. 1984, Nagata et al. 1981, Terpstra et al. 1983, 
Truswell 1978), amino acid composition of the protein 
~ (Sugano et al. 1982, Huff & Carroll 1980, Kritchevsky 1979), 
mineral interactions (Lee et al. 1983, Van Der Meer 1983, 
Samman & Roberts 1984), and the type of carbohydrate 
(Carroll and Hamilton 1975). Lactose compared to sucrose may 
further decrease copper status (Carville and Strain 1989). 
Dietary fructose can increase the signs of CU deficiency 
(Lewis et al. 1990). In our study, sucrose, which is the 
least effective carbohydrate for creating copper deficiency 
was used instead of lactose or fructose. Different species 
also can influence the hypercholesterolemic effect in copper 
study. Rats are the most common animal model used to study 
effects of copper intake on lipids (all of the above 
studies). In the pig, Bruch and co-workers (1975) showed a 
fall in plasma cholesterol level at a constant cu intake 
(1.8 ug/g) as the dietary Zn/Cu ratio decreased from 67:1 to 
4:1. Eisemann and co-workers (1979) showed that there was no 
effect on plasma cholesterol and none of the animals became 
hypercholesterolemia by using Zn/CU ratios of 0.5:1 to 73:1. 
The lowest level of dietary copper (8 ug/g) was four times 
higher than that required to create hypercholesterolemia in 
rats. There was no effect on plasma cholesterol of diets 
containing from 6 to 60 ug cu/g and Zn/Cu ratios from 1 to 
so 
20:1 in chickens (Helwig et al. 1978). There were not many 
mice studies in copper and lipid research. Klevay had a 
study of mice fed diets containing 0.4 - 10 ug CU/mL, plasma 
cholesterol did not change (Klevay 1985). In our mouse 
study, there was no significant difference in the lipids due 
to copper which might be explained if mice are an unsuitable 
animal model. No differences in SOD values among groups 
suggested that we might have failed to produce copper 
deficiency in this study. These results demonstrated the 
hypocholesterolemic effect of the Chinese herb in mice fed a 
hypercholesterolemic diet. 
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Group 
-cu-CH 
(8) 
-cu+CH 
(6) 
+cu-CH 
(8) 
+Cu+CH 
(8) 
Source of 
Variation 
Cu 
CH 
Cu*CH 
TABLE 1 
BODY, LIVER, SPLEEN, AND KIDNEY WEIGHTS 
OF MICE FED HYPERCHOLESTEROLEMIC DIETl 
Body 
(g) 
31. 6±1. 3 
34 .1±1. 5 
30.8+1.3 
33.5±1.3 
0.60 
0.07 
0.97 
Liver 
(g) 
3.1±0.20 
2.5+0.18 
2.9±0.16 
2.9+0.16 
Spleen 
(g) 
0.17+0.0l 
0.12±0.02 
0.14+0.0l 
0.14±0.01 
Analysis of Variance 
p 
0.62 
0.13 
0.16 
Value 
0.64 
0.06 
0.11 
Kidney 
(g) 
0.42±0.02 
0.39+0.02 
0.14±0.01 
0.38±0.02 
0.19 
0.81 
0.32 
1. Mean±SEM, N = 6-8. 
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Group 
-cu-CH 
(8) 
-cu+CH 
(6) 
+cu-CH 
(8) 
+cu+CH 
(8) 
Source of 
Variation 
Cu 
CH 
Cu*CH 
TABLE 2 
PLASMA GLUCOSE, CHOLESTEROL, TRIGLYCERIDE, 
AND ERYTHROCYTE SOD OF MICE FED 
HYPERCHOLESTEROLEMIC DIETl 
Glucose 
(mg/dl) 
289.0±16.5 
346.5±19.0 
323.6±16.5 
327.3±16.5 
0.66 
0.09 
0.13 
Cholesterol 
(mg/dl) 
182.0±8.7 
174.8±10.0 
200.0± 8.7 
167.5+ 8.9 
Triglyceride 
(mg/dl) 
69.9±5.2 
50.5+6.0 
53.6±5.2 
54.1+5.2 
Analysis of Variance 
P Value 
0.56 
0.042 
0.17 
0.26 
0.09 
0.08 
1. Mean±SEM, N = 6-8. 
2. Significant difference. 
SOD 
(U/g Hb) 
881±38 
890±49 
856±38 
889±41 
0.76 
0.62 
0.78 
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CHAPTER VI 
THE EFFECTS OF FRACTIONS FROM A CHINESE HERB 
ON PLASMA GLUCOSE AND CHOLESTEROL IN MICE 
FED A HYPERCHOLESTEROLEMIC DIET 
Abstract 
High insulin potentiating activity (IPA) was found in a 
Chinese herb (CH). Three fractions were collected after an 
extract of CH was applied to G-25 Sephadex. Based on the 
results of our previous studies, the crude extract from CH 
had hypoglycemic effects. Therefore the purpose of this 
study was to test the effects of fractions and the 
combinations of fractions from CH on the metabolism of 
glucose and cholesterol. Two experiments were performed. In 
experiment 1, thirty-nine weanling male mice were randomly 
assigned to four groups: fraction 1, 2, or 3 supplemented or 
control. In experiment 2, sixty-one weanling male mice were 
randomly divided into six groups: fraction 1 & 2, 1 & 3, 2 & 
3, 1 & 2 & 3, crude extract, or the control. All mice were 
fed a hypercholesterolemic diet with 1.0% cholesterol and 
0.5% cholic acid. In experiment 1, low chromium diets were 
fed. Each mouse was given 100 ul of fraction(s) or water 
orally by micropipette daily. Experiment 1 and 2 were 
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terminated after 10 and 9 weeks, respectively. The results 
showed that body weight was significantly decreased by 
fraction 1. The tissue weights were not affected. The mean 
plasma glucose was decreased significantly by fraction 1, 1 
& 2, and 1 & 3. Mean plasma insulin was significantly 
decreased by fraction 1 & 2, 1 & 3, 2 & 3, and 1 & 2 & 3. 
The glucose/insulin ratio was increased significantly by 
fraction 1 and 1 & 3. No fraction(s) had hypocholesterolemic 
effects. Fraction 1 alone, 1 & 2, and 1 & J had a 
hypoglycemic effect. 
INDEXING KEY WORDS: 
• Chinese herb. insulin potentiating activity 
• glucose. cholesterol. glucose/insulin ratio 
Insulin potentiating activity is high in a Chinese herb 
(CH) which has been used as a hypocholesterolemic medicine 
in China. In animal studies, CH showed hypocholesterolemic 
effects in pigeons, rats, and mice (Guo and Song 1986, Niau 
et al. 1988, Cheng et al. 1988, Cheng and Stoecker 1990). 
Mean serum cholesterol decreased significantly after 2 
months of supplementations with CH or nicotinic acid 
compared with the control group (P < 0.001) in a study of 
eighty pigeons fed a hypercholesterolemic diet (Guo and song 
1986). In a continuing study in pigeons, CH supplementation 
again decreased serum cholesterol significantly (P < 0.025) 
compared with the control group (Guo and Song 1986). CH in 
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the form of extract or powder also was supplemented to rats 
fed hypercholesterolemic diets (2% cholesterol, 0.5% cholic 
acid) (Niou et al. 1988). After 17 days, mean serum 
cholesterol in rats fed either extract or powder of CH was 
decreased significantly (P < 0.05) compared with the control 
group (Niou et al. 1988). In a study of mice fed normal 
diets, mean serum cholesterol was decreased significantly by 
CH extract 
(P < 0.02) after 6 weeks (Cheng et al. 1988). In another 
study in which mice were fed a hypercholesterolemic diet for 
12 weeks, mean plasma cholesterol was again significantly 
(P < 0.04) decreased (Cheng and Stoecker 1990). 
Because of the hypocholesterolemic effect of CH, 
further study is needed to investigate the components of CH. 
The purpose of this study was to test the effects of 
different fractions of CH separated on Sephadex G-25 on 
glucose and cholesterol in mice fed hypercholesterolemic 
diets. 
Materials and Methods 
Animals. 
Experiment 1: Thirty-nine male weanling mice were 
randomly assigned to four groups: fraction 1, 2, 3, or the 
control. 
Experiment 2: Sixty-one male weanling mice were 
randomly assigned to six groups: fraction 1 and 2, fraction 
1 and 3, fraction 2 and 3, fraction 1 & 2 & 3, crude 
extract, or control. 
Diet and housing. The diet contained 20% casein, 0.3% 
DL-methionine, 48.5% sucrose, 5% cellulose (Celufil), 5% 
corn oil (Mazola), 3.5% modified AIN mineral mix. 1.0% AIN 
vitamin mix, and 0.2% choline bitartrate, 1.0% cholesterol, 
and 0.5% cholic acid. In experiment 1 chromium was omitted 
from the hypercholesterolemic diet. In experiment 2 the AIN 
mineral mix containing chromium was used to formulate the 
hypercholesterolemic diet. Each mouse was given 100 ul of a 
fraction of CH, or the combination of fractions, or water 
orally by micropipette daily. 
The mice were maintained on a 12-h light-dark cycle and 
had access to diet and deionized water ad libitum. Trace 
metal contamination was reduced by using of plastic housing 
and feeding equipment. 
Experiment 1 was finished after 10 weeks. Experiment 2 
was terminated after 9 weeks. Mice were anesthetized and 
exsanguinated by heart puncture. Tissues were weighed and 
plasma (syringes were rinsed by 10,000 units/ml EDTA 
solution) was prepared and frozen. 
Extraction. Chinese herb (CH) was stirred with an 
excess 20:1 of 0.1 N NH40H for 2 hr (w/v) and then 
centrifuged at 1,000 g for 20 min. The supernatant was 
applied to a Sephadex G-25 column (50-150 u particle size, 
60 x 2.6 cm). Three fractions were collected and evaporated 
at room temperature to 1/3 of their original volume for 
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experiment 1 and to 1/10 of their original volume for 
experiment 2. Each combination of fractions was prepared by 
mixing the appropriate fractions and equal concentrations 
were maintained. 
Analysis. Plasma glucose (Kadish et al. 1968) and 
cholesterol (Allain et al. 1974) were analyzed using 
enzymatic methods. Insulin was analyzed by radioimmunoassay 
(Crowley and Garbien 1974). 
Results 
The results showed that in experiment 1 body weight was 
significantly decreased by fraction 1 compared with the 
control group (P < 0.01) (Table 1). In experiment 2 none of 
the combinations of fractions affected body weight (Table 
3). In experiment 1 kidney weight was decreased by fraction 
3 alone compared to the control group (P < 0.04) (Table 1). 
Spleen and liver weights were not affected by single 
fraction supplementation (Table 1). The weights of liver, 
kidney, and spleen were not affected by the combinations of 
fractions (Table 3). 
The mean plasma glucose in the fraction 1 supplemented 
group (245 mg/dl) was significantly decreased compared with 
the control group (294 mg/dl) (P < 0.04) (Table 2). The mean 
plasma glucose in mice supplemented with combinations of 
fraction 1 & 2 (195 mg/dl) or fraction 1 & 3 (188 mg/dl) was 
significantly decreased (P < 0.04 and P < 0.02, repectively) 
compared to the control group (Table 4). 
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The mean plasma insulin concentrations in groups 
supplemented with combinations of fraction 1 & 2, fraction 1 
& 3, fraction 2 & 3, or fraction 1 & 2 & 3 were all 
significantly lower than the control group (Table 4). The 
plasma glucose/insulin (G/I) ratio of the fraction 1 group 
(32.9) was higher than the control (20.1) group (P < 0.05) 
(Table 3}. The plasma glucose/insulin ratio of fraction 1 & 
3 group (226.5) was much higher than the control group (7.5) 
(P < 0.005) (Table 4). Five animals in this study had plasma 
insulin concentrations that were not distinguishable from 
zero. Three of these animals were in the group supplemented 
with the combination of fractions 1 & 3. Thus, we are not 
certain if the high G/I ratio in this group is a real effect 
of fraction 1 & 3 or an artifact. 
No fraction alone nor the combinations of fractions 
decreased plasma cholesterol. The mean plasma cholesterol 
concentration in mice fed fraction 2 & 3 (240 mg/dl) was 
significantly (P < 0.01) higher than the control group (194 
mg/dl) (Table 4). 
Discussion 
In contrast to the crude extract from CH, none of the 
fractions or the fraction combinations showed a 
hypocholesterolemic effect. The combination of fraction 2 
and 3 even increased plasma cholesterol. The 
hypocholesterolemic effect from CH does not occur with 
supplementation of any of the single fractions or 
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combinations of fractions. The active hypocholesterolemic 
substance might become inactive through the purification 
procedure. Further study is needed to try to purify the 
hypocholesterolemic substance through the proper column, 
buffer, and pH. This study showed the combination of 
fraction 2 and 3 had a negative impact and actually raised 
plasma cholesterol. 
In this study, a significant hypoglycemic effect was 
found when fraction 1 was supplemented alone. The 
combination of fraction 1 and 2 or fraction 1 and 3 also 
lowered plasma glucose significantly. This might be 
explained by insulin potentiation. Because CH had high 
insulin potentiating activity (IPA) in vitro, we expected a 
hypoglycemic effect in the animal study. But the crude 
extract from CH had a hypocholesterolemic effect (Cheng et 
al. 1988, Cheng and Stoecker 1990) instead of a hypoglycemic 
effect. In this study, fraction 1, fraction 1 and 2, 
fraction 1 and 3 again had a hypoglycemic effect instead of 
a hypocholesterolemic effect. The mechanism is not clear; 
perhaps the crude extract was not pure enough to be able to 
strongly affect glucose metabolism producing a hypoglycemic 
effect in animals. Fraction 1 alone and the combination of 
fraction 1 & 3 had the highest G/I ratio. This suggests that 
fraction 1 or the combined form of fraction 1 and 3 
potentiate insulin sensitivity. 
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Fraction 1 also had lowest weight gain compared with 
the control group. To know the mechanism, further study is 
needed. 
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TABLE 1 
WEIGHT GAIN AND TISSUE WEIGHTS IN MICE 
SUPPLEMENTED WITH FRACTION li 2, 
OR 3 OF CH (EXPERIMENT 1) 
Wt gain Liver wt Kidney wt 
(g) (g) (g) 
Spleen wt 
(g) 
------------------------------------------------------------
Fret 1 
Fret 2 
Fret 3 
Control 
Sources of 
variation 
Fl vs Ct 
F2 vs Ct 
F3 vs Ct 
9.8±0.7 
11.4±0.7 
11.6±0.7 
12.8±0.8 
0.20 
0.29 
2.06+0.11 0.30±0.02 
2.11+0.11 0.30+0.02 
2.17±0.11 0.28±0.02 
2.32+0.12 0.33±0.02 
Analysis of variance 
P value 
0.12 
0.20 
0.36 
0.22 
0.19 
0.042 
1. Values are means± SEM; n = 9-10. 
2. Significant difference from control group. 
0.13±0.01 
0.14+0.0l 
0.13±0.01 
0.14±0.01 
0.36 
0.55 
0.25 
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TABLE 2 
PLASMA GLUCOSE, INSULIN, G/I RATIO AND 
CHOLESTEROL IN MICE SUPPLEMENTED 
WITH FRACTION 1, 2, OR 3 OF 
CH (EXPERIMENT 1)1 
Glucose Insulin G/I Cholesterol 
(mg/dl) (uU/ml) (ratio) (mg/dl) 
------------------------------------------------------------
Fract 1 
Fract 2 
Fract 3 
Control 
Source of 
variation 
Fl vs Ct 
F2 vs Ct 
F3 vs Ct 
244.8+16.2 
257.0±18.0 
249.4±16.2 
293.9±17.0 
0.042 
0.15 
0.07 
8.5±5.0 32.9±4.1 
14.9+5.5 24.0+4.6 
30.4±4.9 18.4±4.1 
16.5±5.5 20.1+4.6 
Analysis of Variance 
0.29 
0.83 
0.07 
p Value 
0.052 
0.55 
0.78 
1. Values are means+ SEM; n = 9-10. 
243.6±15.2 
261.7±16.0 
238.1+15.2 
247.5±16.0 
0.86 
0.53 
0.67 
2. Significant difference from control group. 
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TABLE 3 
MEAN BODY WEIGHT AND TISSUES WEIGHTS 
OF MICE SUPPLEMENTED WITH THE 
COMBINATIONS OF FRACTIONS 
Group Weight 
Gain 
(g) 
Fra 
1&2 
Fra 
1&3 
Fra 
2&3 
7.9+0.8 
7.6+0.8 
6.0+0.8 
Fra 7.8±0.8 
1&2&3 
Crude 7.4+0.7 
extr 
Contr 7.6±0.7 
OF CH (EXPERIMENT 2)1 
Liver 
(g) 
2.4200±0.0905 
2.4749+0.0905 
2.5293±0.0905 
2.4599±0.0905 
2.4175±0.0863 
2.3379±0.0863 
Kidney 
(g) 
Spleen 
(g) 
0.3163±0.0253 0.1301±0.2785 
0.3247±0.0253 0.1263+0.2785 
0.3239+0.0253 0.1515±0.2785 
0.3371±0.0253 0.1279+0.2785 
0.3153±0.0253 0.1292±0.2655 
0.3557±0.0241 0.8073±0.2785 
1. Values are means+ SEM, n = 10-11. 
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TABLE 4 
MEAN PLASMA GLUCOSE, INSULIN, G/I RATIO, 
AND CHOLESTEROL IN MICE SUPPLEMENTED 
WITH COMBINATIONS OF FRACTIONS 
FROM CH (EXPERIMENT 2)1,2 
--------------------------------------------------------Group Glucose Insulin G/I Cholesterol 
(mg/dl) (uU/ml) (ratio) (mg/dl) 
--------------------------------------------------------
F1&2 194.6+10.8a 13.9±2.68 98.7±53.2 209.7±13.2 
Fl&3 188.3±11.4b 11.2±2.78 226.5±56.ld 225.1±14.0 
F2&3 197.6±10.8 15.1+2.68 56.6±53.2 240.0±13.2C 
Fl&2&3 211.8+10.8 21.8+2.6e 12.3+53.2 197.4±13.2 
Extr 214.7±10.3 24.9±2.4 9.1+50.7 196.4±12.6 
Cont 225.2±10.3 31.4+2.4 7.5±50.7 193.6±12.6 
1. Values are means+ SEM; n = 10-11. 
2. The significant differences from control (a: P < 0.05; 
b: P < 0.02; c: P < 0.01; d: P < 0.005; e: P < 0.001). 
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CHAPTER VII 
THE EFFECTS OF A FRACTION FROM CHINESE HERB ON 
PLASMA GLUCOSE AND CHOLESTEROL IN OBESE 
MICE FED A HYPERCHOLESTEROLEMIC DIET 
Abstract 
Three fractions were separated through a medium G-25 
Sephadex column from CH, a Chinese herb which has high 
insulin potentiating activity (IPA). The purpose of this 
study was to test the effects of fraction 1, which had the 
highest IPA, on glucose and cholesterol metabolism in obese 
mice. Nineteen male obese weanling mice were randomly 
assigned to two groups: fraction 1 supplemented group and 
control group. Mice were fed a casein-based 
hypercholesterolemic diet containing 1.0% cholesterol and 
0.5% cholic acid. Each mouse was given 100 ul of fraction 1 
or water orally by micropipette daily. After 7 weeks, 
neither body weights nor liver weights were affected by 
fraction 1. Both kidney and spleen weights were increased 
significantly by fraction 1 supplementation. The mean values 
of plasma glucose, insulin and glucose/insulin (G/I) ratio 
were not affected by fraction 1. However, the mean plasma 
cholesterol in the fraction 1 supplemented group (169 ± 39 
71 
mg/dl) was significantly lower (P < 0.003) than the control 
group (237 ± 47 mg/dl). 
INDEXING KEY WORDS: 
• Chinese herb. insulin potentiating activity (IPA) 
• glucose. insulin. cholesterol. G/I ratio 
Insulin potentiating activity (IPA) was checked in 
twenty-four Chinese herbs (Cheng et al. 1988) which have 
been used as hypoglycemic and hypocholesterolemic agents for 
centuries in China. CH had the highest IPA among these 
Chinese herbs. However, there have been only a few reports 
of the effects of CH on lipid metabolism. 
An effect of CH on cholesterol in eighty pigeons fed a 
hypercholesterolemic diet was reported by Guo and Song in 
1986 (Guo and Song 1986). After 2 months of supplementation, 
the results showed that mean serum cholesterol of the CH or 
the nicotinic acid supplemented groups was significantly 
decreased compared with the control group. 
The effects of CH on cholesterol, several enzymes, and 
pathological changes were investigated in thirty-nine rats 
fed either normal or hypercholesterolemic diets (Niou et al. 
1988). After 17 days, serum cholesterol concentrations in 
both groups supplemented with CH extract or CH powder were 
decreased significantly compared to the group fed the 
hypercholesterolemic diet alone. The hepatic ATPase and SDH 
(succinate dehydrogenase) in CH supplemented groups were 
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lower than in the control group. The hepatic G-6-P (glucose-
6-phosphate) in the CH powder supplemented group was lower 
than the other groups. There were many neutral fat drops in 
the lobules of the liver in the mice fed a 
hypercholesterolemic diet without CH supplementation. Both 
CH supplemented groups had very few fat drops and were 
almost like the normal diet group. 
Effects of various doses of CH on lipidemic and 
atherosclerotic changes were tested in forty-six,Japanese 
quail fed a hypercholesterolemic diet for 6 weeks (Wang and 
Jin 1984). The results showed that plasma HDL-cholesterol 
and HDL-cholesterol/total cholesterol ratios in groups 
supplemented with three levels of CH were increased compared 
to the control group. Plasma cholesterol, triglyceride, and 
cholesterol esters in the three CH-supplemented groups were 
decreased compared to the control group. Atherosclerotic 
changes in the aorta with the three levels of CH 
supplementation were less than in the control group, 
especially with the large dose of CH. 
Two studies of mice fed either normal or 
hypercholesterolemic diets both showed that serum 
cholesterol was significantly decreased by CH extract (Cheng 
et al. 1988, Cheng and Stoecker 1990). 
CH was further separated through G-25 Sephadex and 
three fractions were collected. High IPA was found in 
fraction 1 (Cheng and Stoecker 1992). Each fraction and the 
con,binations of fractions were investigated in mice fed 
I 
hypercholesterolemic diets. The results showed that 
fraction 1 or the combinations containing fraction 1 caused 
a hypoglycemic effect instead of the hypocholesterolemic 
effect previously obtained from the crude CH extract (Cheng 
et al. 1988, Cheng and Stoecker 1990). The purpose of this 
study was to investigate a possible hypoglycemic effect with 
fraction 1 of CH in older obese mice. 
Materials and Methods 
1 Animals and diets. Nineteen obese male mice (51 days 
old) were randomly assigned to two groups: fraction 1 or 
control. The diet contained 20% casein, 0.3% DL-methionine, 
48.5% sucrose, 5% cellulose (Celufil), 5% corn oil (Mazola), 
3.5% AIN mineral mix or 3.5% modified AIN mineral mix, 1.0% 
AIN vitamin mix, 0.2% choline bitartrate, 1.0% cholesterol, 
and 0.5% cholic acid. Chinese herb (CH) was extracted with 
0.1 N NH40H (1:20) and centrifuged (1,000 x g). The 
supernatant was applied to a Sephadex G-25 column (50-150 u 
of particle size, 60 x 2.6 cm). Three fractions were 
separated. The first fraction was collected and evaporated 
to one-third of its original volume at room temperature. 
Each mouse was given 100 ul of fraction 1 of CH or water 
orally by micropipette daily. The mice were maintained on a 
12-h light-dark cycle and had access to diet and deionized 
water ad libitum. Trace metal contamination was reduced by 
use of plastic housing and feeding equipment. After 7 weeks, 
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mice were fasted 14 hr and then were given an oral glucose 
load (1 mg glucose/g body weight as a 50% solution) 60 
minutes before sacrifice. Mice were anesthetized and 
exsanguinated by heart puncture. Tissues were weighed and 
plasma was prepared and frozen. 
Analysis. Plasma glucose (Kadish et al. 1968) and 
cholesterol (Allain et al. 1974) were analyzed using 
enzymatic methods. Insulin was analyzed by radioimmunoassay 
(Crowley and Garbien 1974). 
Results and Discussion 
After 7 weeks, body weights and liver weight were not 
affected by feeding fraction 1 (Table 1). Both kidney and 
spleen weights were increased significantly in the 
supplemented group (Table 1). The group supplemented with 
fraction 1 of CH had higher spleen weight than the control 
group. A study reported that the supplementation of CH in 
mice caused proliferation in the T lymphatic cell-dependent 
area (including thymus and lymphatic cells around the 
central artery in the spleen) and in the B lymphatic cell-
dependent area (including the white pulp and germinal center 
in the spleen) (Guo and Song 1986). These results suggested 
a positive effect of CH in the immune system. The spleen 
weight increase in the fraction 1 supplemented group might 
be caused by the proliferation of lymphatic cells. The basis 
for an effect on kidney weight by fraction 1 of CH is 
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unknown. No mention of such an effect was found in the 
literature, indicating a need for further study. 
Mean plasma glucose, insulin and glucose/insulin (G/I) 
ratio were not affected by fraction 1 (Table 2). However, 
the mean plasma cholesterol in the group supplemented with 
fraction 1 (169 ± 39 mg/dl) was significantly lower 
(P < 0.003) than the control group (237 + 47 mg/dl) (Table 
2). In this study, fraction 1 played the same role as the 
crude extract of CH (Cheng et al. 1988, Cheng and Stoecker 
1990) which was to produce a hypocholesterolemic effect. The 
same hypocholesterolemic effect by CH was reported in 
pigeons, rats and Japanese quail (Guo and Song 1986, Niou et 
al. 1988, Wang and Jin 1984). A study in rats showed that 
SDH decreased as serum cholesterol decreased with CH 
supplementation (Niou et al. 1988). The lower plasma 
cholesterol with the supplementation of CH also can be 
explained by the conversion of cholesterol to cholic acid 
(Xu and Li 1987). (7-3H)-cholesterol was added to hepatic 
cells with 3 levels of CH in vitro. The results showed that 
the lowest concentration had the most effect on increasing 
conversion of cholesterol to cholic acid. 
Fraction 1 did not have a hypoglycemic effect in the 
older obese mice as it did in the weanling lean mice. There 
were many differences, such as weight, age, diets, length of 
the experiment, and blood sampling times. More study needs 
to be done to understand the mechanism of 
hypocholesterolemic effect by CH in obese mice. 
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GROUP 
TABLE 1 
BODY, LIVER, KIDNEY, AND SPLEEN WEIGHT 
IN OBESE MICE SUPPLEMENTED 
WITH FRACTION 1 OF CHl 
WEIGHT GAIN 
(g) 
LIVER 
(g) 
KIDNEY 
(g) 
SPLEEN 
(g) 
FRACTION 1 6.2±1.6 3.95±.88 o.39±0.052 o.08+0.012 
---~--------------------------------------------------------
CONTROL 6.8+2.7 4.28+.95 0.35+0.04 0.07±0.01 
P VALUE 0.6 0.4 0.00062 
1. Values are means± SEM; n = 10. 
2. Significant difference from control group. 
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TABLE 2 
MEAN VALUE OF GLUCOSE, INSULIN, G/I RATIO, AND. 
GROUP 
FRACTION 
CONTROL 
I 
' 
p 
Value 
CHOLESTEROL IN OBESE MICE SUPPLEMENTED 
WITH FRACTION 1 OF CHl 
GLUCOSE 
(mg/dl) 
393.6±72.3 
417.3+36.1 
0.4 
INSULIN 
(uU/ml) 
63.7±22.3 
79.3+25.6 
0.2 
I/G 
(ratio) 
7.3+4.0 
5.7+0.1 
0.6 
CHOLESTEROL 
(mg/dl) 
168.7±39.0 
237.1+46.9 
0.0032 
1. Values are means+ SEM; n = 9 -10. 
2. Significant difference from control group. 
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CHAPTER VIII 
CHROMIUM INTERACTION WITH NUCLEIC ACIDS 
IN RAT LIVER 
Abstract 
Effects of chromium on nucleic acid metabolism both at 
nutritional and toxicological concentrations have been 
observed. The chromium and nucleic acid concentration of rat 
liver extracts from rats fed J levels of dietary chromium 
were monitored to determine the effects of dietary chromium 
on nucleic acids in rats. Male Sprague Dawley rats were fed 
a low chromium diet (JO ug Cr/kg) or the same diet 
supplemented with 1 or 100 mg chromium as CrClJ per kg of 
diet. Liver extracts from 8 week old rats were 
chromatographed on Sephadex G-15. Elution profiles of RNA, 
DNA and protein from rats consuming either the low chromium 
diet or the diet supplemented with 1 mg chromium per kg of 
diet were similar. Chromium was associated with both the RNA 
and DNA fractions as well as the high molecular weight 
(> 1500 daltons) material. Liver extracts of animals 
supplemented with 100 mg/Cr per kg diet displayed increased 
chromium associated with fractions of molecular weight 
greater than 1500 but low molecular weight fractions were 
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similar to those from animals fed the lower chromium diets. 
Liver chromium concentrations of animals fed the low 
chromium diet and of those supplemented with 1 mg chromium 
per kg of diet were similar. The mean DNA concentration of 
livers from animals fed the low chromium diet supplemented 
with 100 ug chromium was greater than DNA concentrations of 
livers from animals fed the low chromium diet or the low 
chromium diet plus 1 mg chromium/kg diet. The binding of 
chromium to DNA may have an effect on DNA stability leading 
to decreased degradation and therefore elevated 
concentrations. However, a direct effect of chromium on DNA 
synthesizing or degradative enzymes cannot be excluded. 
These results confirm that chromium is associated with 
nucleic acids. Dietary chromium alters the chromium in 
fractions with a molecular weight greater than 1500 daltons 
and dietary chromium also appears to have an effect on DNA 
concentration. 
INDEXING KEY WORDS: 
• Chromium. nucleic acids. RNA. DNA 
Introduction 
An interaction of chromium with nucleic acids was first 
proposed by Herrman and Speck in 1954. They suggested that 
the treatment of tissues with chromium or chromate reduced 
the amount of nucleic acids (Herrmann and Speck 1954). Later 
Wacker and Vallee found that chromium bound to nucleic acids 
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so tightly that even ethylenediamine tetraacetic acid (EDTA) 
(10-4 M) couldn't remove it. They also detected chromium 
concentrations in tissue (Wacker and Vallee 1959). Recently 
the interaction between chromium and nucleic acids has been 
investigated in terms of toxicology and physiology. Tamino 
and co-workers showed that Cr (III) in vitro bound to 
mammalian DNA and RNA (Tamino et al. 1981). Okada and 
collaborators have shown that trivalent chromium added to 
DNA and RNA synthesizing systems in vitro significantly 
stimulated RNA synthesis (Okada et al. 1982, 1983, 1984). 
They also postulated that chromium is present in 
regenerating rat liver in vivo in the form of a chromium-
protein of approximately 70,000 daltons containing between 4 
and 5 atoms of chromium, corresponding to approximately 
3,600 ug chromium/g protein; the increase in RNA synthesis 
with Cr(III)-bound DNA is proportional to the molar binding 
ratio of Cr(III) to DNA (Okada et al. 1982, 1983, 1984). 
This enhancement is possibly due to an increase in the 
chromatin and causes an increase in the number of initiation 
sites on DNA (Okada et al. 1982, 1983, 1984). The present 
study was designed to reexamine the validity of reported 
chromium concentrations in tissue and to investigate 
possible associations between RNA, DNA and dietary chromium 
under carefully controlled conditions. 
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Materials and Methods 
Animals and diets. Male Sprague Dawley rats, 45-50g, 
were divided into three groups and fed either a low Cr diet 
or a low Cr diet plus either 1 mg Cr or 100 mg Cr as 
chromium chloride per kg of diet. Chromium concentration of 
the low Cr diet was approximately 30 ng/g. After eight to 
ten weeks, rats were sacrificed and livers were removed, 
rinsed, and stored on ice or frozen at -200 c. Cold liver 
samples were homogenized with an equal weight of water and 
centrifuged at 10,000 rpm for 15 minutes. The supernatant 
I 
was applied to a Sephadex G-15 column and eluted with water. 
RNA was determined by an orcinal methhod (Keleti and Lederer 
1974), DNA by a diphenylamine procedure (Keleti and Lederer 
1974) and protein by the Biorad method (Bio-Rad Protein 
Assay Kit). Chromium was determined by atomic absorption 
spectroscopy as previously described (Anderson and Kozlovsky 
1985). 
Results 
The elution profiles of RNA, DNA, protein and chromium 
were all similar in liver extracts from animals consuming 
either the low Cr diet or the low Cr diet plus 1 mg Cr per 
kg of diet (Figure 1 & 2). 
Chromium concentration of the hepatic nucleic acids was 
5 ± 1 ug/g dry weight of liver in the animals fed the low Cr 
diet and the low diet supplemented with 1 ug Cr/g diet. 
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The increased amount of Cr was primarily associated 
with the high molecular weight material. The elution pattern 
and amount of the low molecular weight chromium were similar 
in the liver extracts from animals raised on a low Cr diet 
and also the low Cr diet supplemented with either 1 or 100 
mg Cr per kg of diet (Figure 1 & 2). 
The amount of DNA in the livers from animals fed the 
low chromium diet supplemented with 100 mg Cr/kg diet 
appeared to be greater than that of livers from animals fed 
the low Cr diet or the low Cr diet plus 1 mg Cr/kg diet 
(Figure 1 & 2). 
'1 
Discussion 
The results presented here support previous 
observations that chromium is associated with nucleic acids. 
The chromium concentrations obtained in the present study, 
under careful control of contamination, are lower than those 
reported earlier but are still much in excess of chromium 
concentrations in other materials. The chromium 
concentration in blood, for example, is close to 1 ng/g dry 
weight, approximately three orders of magnitude lower than 
the concentrations in nucleic acids reported here. 
1 
As shown in Figure 1, our procedure did not separate 
the large size nucleic acids from accompanying protein. A 
nucleoprotein from horse liver has been reported previously 
to contain very high chromium concentrations. Alternately, 
much of the chromium could be part of a specific, chromium-
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binding protein, such as demonstrated by Okada and his co-
workers (Ohba et al 1986). 
The elution profile of RNA, DNA, protein and chromium 
were all similar in liver extracts from animals consuming 
either the low Cr diet or the low Cr diet plus 1 mg Cr per 
kg of diet. The elution of Cr was greater in the first peak 
of liver extracts from the animals supplemented with 100 mg 
Cr/kg diet compared to the low Cr and diet supplemented with 
1 mg Cr/kg diet. Apparently the low molecular weight Cr 
compounds are regulated at relatively constant levels while 
the excess Cr is associated with complexes with a molecular 
weight of 1500 daltons or greater. 
The elevated DNA concentration in the animals 
supplemented with the highest levels of chromium, although 
reproducible, needs to be studied further. The binding of 
chromium to DNA may have an effect on DNA stability leading 
to decreased degradation and therefore elevated 
concentrations. However, a direct effect of DNA on synthetic 
or degradative enzymes cannot be excluded. 
These results confirmed that chromium is associated 
with nucleic acids amd that DNA and RNA fractions do contain 
substantial amounts of chromium. Dietary Cr alters the Cr in 
fractions with a molecular weight greater than 1500 daltons. 
Dietary Cr appears to affect DNA concentration. 
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CHAPTER IX 
EFFECTS OF CHROMIUM DEPLETION ON HEPATIC 
NUCLEIC ACIDS IN GUINEA PIGS 
Abstract 
Effects of dietary Cr and ascorbate on several 
par~meters including growth and nucleic acids were 
I 
I 
investigated in guinea pigs. Thirty-six male weanling (181 
g) Hartley animals were grouped in a 2 x 2 factorial design. 
Diets contained <60 ppb Cr (-Cr) or were supplemented with 2 
ppm Cr as CrC13 (+Cr). Animals were given an oral supplement 
of 1 mg (-C) or 10 mg (+C) ascorbate daily. Groups were : 
-cr-c, -cr+c, +cr-c, and +cr+c. At 21 weeks the mean body: 
weight of the Cr-depleted animals was significantly reduced 
(P < 0.0003). Mean weight of pancreas, liver, testes and 
epididymal fat were also significantly lower with Cr 
depletion. Ascorbate depletion, however, increased liver 
weight. Hepatic DNA of the er-depleted groups was lower (1.7 
mg DNA/g liver) than the Cr-supplemented animals (2.58 mg/g) 
(p < 0.005). Hepatic RNA was similarly reduced by Cr 
depletion (8.89 mg/g vs. 10.57 mg/g) (P < 0.03). Chromium 
depletion decreased growth apparently through an effect on 
nucleic acids. 
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Introduction 
In 1954 Herrmann and Speck reported that the treatment 
of tissues with chromiun or chromate reduced the amount of 
nucleic acids (Herrmann and Speck 1954). Wacker and Vallee 
(1959) detected chromium in tissue and found that the 
concentration was very high. They also found that chromium 
tightly bound to nucleic acids and was not able to be 
removed by repeated treatment with 
ethylenediaminetetraacetic acid (EDTA). Edwards et al. 
reported that chromium accumulated in cell nucleic in rat 
liver (Edwards et al 1961). Andronikashivili and co-workers 
found that DNA isolated from rat sarcoma and human leukemic 
cells showed a high concentration of chromium 
(Andronikashivili et al. 1974, 1976). Tamino et al. 
indicated that chromium (III) in vitro binds to mammalian 
DNA and RNA (Tamino et al. 1981). Ohba and co-workers (1986) 
have reported that in vitro RNA synthesis was stimulated by 
the complex of Cr(III)-bound DNA. All these studies 
suggested an effect of Cr (III) on nucleic acid metabolism. 
This study was designed to investigate the effects of 
dietary chromium and ascorbic acid depletion on several 
parameters including growth and nucleic acids. Guinea pigs 
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were used because they have a requirement for vitamin c in 
the diet. 
Materials and Methods 
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Animals and diets. Thirty-six Hartley male guinea pigs 
(Sasco, Inc., Omaha, NE) with a mean body weight of 181 g 
were randomly assigned to chromium and ascorbate treatment 
groups in a 2 x 2 factorial design. The four groups were: 
ascorbate depletion and chromium supplementation; ascorbate 
supplementation and chromium supplementation; ascorbate 
depletion and chromium depletion; ascorbate supplementation 
and chromium depletion. 
The diet contained (g/kg): 370 dextrose, 300 casein, 30 
L-arginine HCl, 150 cellulose (Celufil), 70 corn oil, 50 
mineral mix, 35 potassium acetate and 22 vitamin mix without 
ascorbate. The mineral mix contained (g/kg): 600 CaHP04, 80 
NaCl, 100 MgO, 0.90 ZnC03, 1.8 MnC03, 0.25 CuC03, 0.035 
KIOJ, 0.0044 NaSe03.5H20, 1.42 FeS04 and a quantity of 
sucrose sufficient to make 1 kg. Diets contained< 60 ug 
Cr/kg diet (-Cr) or were supplemented with 2 mg Cr as 
CrClJ/kg diet (+Cr). The diet was mixed with deionized water 
to form balls approximately 35 mm in diameter. Animals were 
dosed orally with 1 mg ascorbate/day (-Cr) or with 10 mg/day 
(+Cr). 
Animals had ad libitum access to food and deionized 
water from ceramic cups. They were housed in plastic cages 
to reduce trace mineral contamination. 
Guinea pigs were weighed weekly. The study was 
terminated after 21 weeks. Prior to necropsy, animals were 
weighed and fasted overnight. Six hours before sacrifice, 
each guinea pig was dosed by micropipette with 90 ul 
(1.8 uCi of L-(carboxy1-14c) ascorbate (for the ascorbate 
study) and placed in a sealed metabolic cage with a pumped 
air and exhaust. Animals were anesthetized in the metabolism 
cages with nitrous oxide gas and then exsanguinated by heart 
puncture. Liver samples were frozen immediately in liquid 
nitrogen. Hepatic RNA, DNA and protein were separated based 
on the preferential solubility of nucleic acids in hot 
trichloroacetic acid (Keleti and Lederer 1974). Hydrolyzed 
RNA was estimated by addition of orcinal reagent (Keleti and 
Lederer 1974). DNA was estimated using the diphenylamine 
reaction (Keleti and Lederer 1974). 
Analysis. The Statistical Analysis System (SAS) was 
used to evaluate treatment effects. Data were analyzed as a 
2 x 2 factorial design. The generalized linear model (GLM) 
was used for analysis of variance and least squares means 
determination. 
Results and Discussion 
The mean body weight of the chromium supplemented group 
was higher (P < 0.0003) than the Cr-depleted group. Roginski 
and Mertz suggested several years ago that chromium affected 
growth through protein synthesis (Roginski and Mertz 1967). 
Mean hepatic RNA and DNA of the Cr-supplemented group 
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were higher than the Cr-depleted group (P < 0.05). The mean 
hepatic DNA of the ascorbate supplemented group tended to be 
higher than the ascorbate-deprived group (P < 0.07) (Table 
1). The concentration of hepatic RNA (8-12 mg/g) in our 
study was higher than the hepatic RNA value (5-8 mg/g) 
reported by Vary and Kimball (Vary and Kimball 1992). Okada 
and co-workers reported that RNA synthesis was stimulated by 
the Cr(III)-complexes of DNA (Okada et al 1981). The effect 
of Cr(III) on RNA synthesis by DNA and chromatin isolated 
from mouse liver was investigated in comparison with seven 
oth~r inorganic metals. Cr(III) showed significant 
! 
stimulation on RNA synthesis when incubated with DNA or 
chromatin prior to the addition of RNA polymerase. The 
Cr(III)-complexes of DNA and chromatin also showed 
significantly enhanced template activities (Okada et al 
1981) and caused an increase in the number of initiation 
sites (Ohba et al. 1986). The enhancement of RNA synthesis 
with Cr(III)-bound DNA is proportional to the molar binding 
ratio of Cr(III) to DNA, and is possibly due to an increase 
in the number of initiation sites on DNA (Okada et al, 
1982). The enhancement of RNA synthesis in mouse liver was 
without altering the pool size of nucleotides (Okada et al. 
198~). These results of previous studies might explain the 
increasing RNA content in our study. 
In contrast with our result of DNA content, the 
previous study showed that the synthesis of DNA in mouse 
liver were not significantly changed by Crcl3 administration 
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(Okada et al. 1983). But our guinea pig study lasted for 20 
weeks instead of 48 hr as in Okada's study. Our previous 
study in rats for 8 weeks also showed DNA enhancement with 
i 
Cr ~upplementation (Cheng et al. 1990). These results 
suggested that the Cr-bound DNA might play an important role 
I 
in DNA stability causing the elevated concentrations. Our 
results suggested that long-term chromium supplementation in 
animals resulted in enhancement of DNA content. 
In our study, body weights and RNA and DNA 
concentrations were all increased significantly in chromium 
supplemented groups. Combining these two results, one 
! 
conclusion may be drawn: chromium may affect protein 
synthesis through an effect on nucleic acids. 
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Group 
TABLE 1 
WEIGHT GAIN AND HEPATIC RNA AND DNA 
OF GUINEA PIGSl 
Body Weight RNA DNA 
(g) (mg/g liver) (mg/g liver) 
------------------------------------------------------------
-cr-c 
-cr+c 
+cr-c 
+cr+c 
Source of 
Variation 
Cr 
C 
Cr*C 
653 ± 26 
618 ± 23 
752 ± 25 
715 + 25 
0.00032 
0.16 
0.98 
1. Mean± SEM, n=8-10. 
9.11 ± 0.72 
8.67 ± 0.67 
9.74 ± 0.67 
11.41 + 0.67 
Analysis of Variance 
P Value 
0.022 
0.35 
0.13 
2. Significant difference. 
1.68 ± 
2.07 ± 
2.15 + 
2.88 ± 
0.052 
0.07 
0.57 
0.31 
0.28 
0.30 
0.30 
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CHAPTER X 
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
summary 
This research evaluated the effects of chromium on the 
metabolism of lipids, glucose, and nucleic acids. CH, a 
Chinese herb which has high insulin potentiating activity, 
investigated for its effects on the metabolism of glucose, 
lipids, and insulin. 
Eight objectives and hypotheses are listed in the 
introduction of this dissertation. The significance level is 
set at P < 0.05. Each hypothesis will be addressed 
individually; then other general conclusions and 
recommendations will be discussed. 
Hypothesis one stated that there will be no significant 
differences in blood glucose or cholesterol between Cr-
supplemented and Cr-depletion groups in mice. Hypothesis one 
is accepted because blood glucose and cholesterol were not 
changed by Cr-supplementation in mice. 
Hypothesis two stated that there will be no significant 
differences in blood glucose or cholesterol due to CH-
supplementation in mice. Hypothesis two is rejected because 
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blood cholesterol was significantly decreased by CH 
supplementation in mice. 
Hypothesis three stated that there will be no 
significant differences in blood glucose or cholesterol due 
to CH- or cu- supplementation in mice fed a 
hypercholesterolemic diet. Hypothesis three is rejected 
because blood cholesterol was decreased significantly by CH 
supplementation. 
Hypothesis four stated that there will be no 
significant differences in the blood glucose or cholesterol 
of mice supplemented with individual fractions of CH and fed 
a hypercholesterolemic diet. Hypothesis four is rejected 
because plasma glucose of the fraction 1 supplemented group 
was significantly decreased compared with the control group. 
Hypothesis five stated that there will be no 
significant differences in the blood glucose or cholesterol 
of mice supplemented with combinations of CH fractions and 
fed a hypercholesterolemic diet. Hypothesis five is rejected 
because plasma glucose of mice supplemented with the 
combination of fractions 1 & 2 or fractions 1 & 3 was 
decreased significantly compared with the control group. 
Hypothesis six stated that there will be no significant 
differences in the blood glucose or cholesterol due to 
supplementation of fraction 1 of CH in the obese mice. 
Hypothesis six is rejected because plasma cholesterol was 
decreased significantly in the fraction 1 supplemented 
group. 
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Hypothesis seven stated that there will be no 
significant differences in hepatic RNA and DNA between Cr-
supplementation and er-depletion rats. Hypothesis seven is 
rejected because the mean DNA concentration of livers from 
animals supplemented with 100 ug chromium/kg diet was 
greater than DNA concentrations of livers from animals fed 
the low chromium diet. 
Hypothesis eight stated that there will be no 
significant differences in hepatic RNA and DNA between 
Cr- supplementation and Cr- depletion guinea pigs. 
Hypothesis eight is rejected because both hepatic RNA and 
DNA were increased significantly in er- supplementation 
group compared with er-depletion group. 
Conclusions 
This research investigated the effects of chromium on 
the blood concentrations of glucose and lipids and on 
hepatic nucleic acids. Based upon the hypothesis that GTF 
(glucose tolerance factor) affects glucose utilization, we 
did several studies on IPA (insulin potentiating activity) 
of Chinese herb to find one with high IPA (CH). Studies 
included IPA assays in vitro and animal studies with 
measurement of glucose, lipids, and nucleic acids. 
The chromium studies showed no effects on the blood 
glucose and cholesterol, but the concentrations of hepatic 
nucleic acids did change with chromium supplementation. In 
these studies of chromium supplementation in mice and guinea 
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pigs, chromium had no effect on the metabolism of glucose 
and lipids, but chromium did affect nucleic acids. 
The studies of Chinese herb (CH) showed different 
results between the crude extract from CH and the fractions 
from CH. The conclusions are that the crude extract from CH 
had hypocholesterolemic effect in mice and the fractions 
from CH had hypoglycemic effects in mice. Only older obese 
mice presented a hypocholesterolemic effect with fraction 1 
supplementation. 
Recommendations 
Mice are so small that it is difficult to get enough 
blood and to do repeated measurements. It is important to 
check blood glucose and cholesterol initially during 
treatment. If larger animals are available, a complete 
glucose tolerance test can be done which is more accurate 
than fasting blood glucose or blood glucose only at 60 or 90 
minutes after an oral glucose load. More blood can be drawn 
from the larger animal, so more indices such as 
triglycerides, HDL-cholesterol, and LDL-cholesterol can be 
further determined. 
The finding that dietary chromium influences the 
chromium concentrations in a high molecular weight fraction 
of rat liver extracts from rats fed 3 levels of dietary 
chromium needs further study. Further purification needs to 
be done to identify the complex of chromium and nucleic 
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acids which might play an important role in the metabolism 
of nucleic acids. 
Our studies showed that the crude extract from CH had a 
hypocholesterolemic effect in mice. Why the fraction(s) 
after purification didn't have the same effect as the crude 
extract did is a major question. Further study is needed to 
find the proper methods for better purification for CH. 
Since fraction 1 had a hypoglycemic effect in animal 
studies, further study of its chemical structure is needed. 
More animal studies, especially with larger animal models 
are needed to test more biochemical indices in the blood. 
The metabolism of glucose needs to be further investigated 
in non-insulin dependent (type II) diabetic animal models. 
In addition to determinations of blood glucose and insulin, 
insulin receptors also need to be assayed. 
In our study, fraction 1 showed a hypocholesterolemic 
effect in adult obese mice (models for NIDDM) instead of 
hypoglycemic effect. Further studies are needed in this 
older obese animal model. 
Fraction 1 had the highest IPA among three fractions 
from CH. It also had a hypoglycemic effect on weanling lean 
mice and a hypocholesterolemic effect on older obese mice. 
Therefore studies of chemical structure and biological 
function of fraction 1 should be continued. After the animal 
studies have been done, finally more human studies are 
needed. 
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APPENDIX A 
ASSAYING OF INSULIN POTENTIATING ACTIVITY 
Plastic containers were used exclusively for fat cell 
isolation and assay. Two rats were sacrificed by 
decapitation and their epididymal fat pads removed. The 
distal portion of the fat pads was rinsed with 0.9% NaCl, 
minced with scissors, and incubated at 370c for 40 min in 6 
mL of Krebs Ringer Phosphate (KRP) buffer containing 12 mg 
of collagenase in a water bath shaker at 200 rpm. The KRP 
contained 118 mM NaCl, 1.3 mM cacl2 , 1.2 mM Mgso4 , 1 mM 
KH2P04, and 16.2 mM Na2HP04-HCl (pH 7.4). The digested 
tissue was passed through a silk screen using a 10-mL 
syringe. The preparation was then washed three times by 
centrifugation with KRP containing 2% albumin. Both KRP and 
KRP-albumin were millipore filtered and gassed with o2 • The 
material below the floating fat cells and any fat above the 
adipocytes were removed by aspiration. KRP-albumin (10 mL) 
was added to disperse the washed fat cells. Fats cells 
remained viable for at least 4 h. 
Insulin and indicated amount of sample to be tested 
were added to tubes that contained 1.9 mL of KRP-albumin, 
0.4 uci(u-14c) glucose (313 Ci/mol), and 67.5 ug of 
dextrose. Adipocytes (0.06 mL) were added, and caps 
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containing center wells were used to seal the tubes. After 
incubation for 2 hat 370c and shaking at 150 rpm, 0.2 mL of 
hyamine hydroxide (lOX) was added to the center well, and 
0.3 mL of 2 N H2so4 was injected into the incubation mixture 
to stop the reaction. The tubes were incubated for 30 min to 
allow the hyamine to trap 14co2 • The center wells were 
removed, carefully wiped, and added to 10 mL of Aquasol II 
and counted in a beta counter. 
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APPENDIX B 
SEPARATION OF RNA AND DNA IN LIVER 
1. 0.5 g of liver is diluted up to 5 ml with ice-cold 
sucrose reagent A. 
2. Homogenize tissue at 40c. 
3. Add 10 ml of ice-cold TCA reagent B. 
4. Let stand for 30 minutes or longer at 40c. 
5. Wash with 5 ml ice-cold reagent B. centrifuge at 10,000 
rpm for 20 minutes at 40c. Discard the supernatant. 
6. Suspend the precipitate in 5 ml of ethanol at room 
temperature. 
7. Let stand for 30 minutes at room temperature. 
8. Centrifuge at 10,000 rpm for 15 minutes at 40c and 
discard the supernatant. 
9. Repeat steps 6, 7 and 8. 
10. Add 5 ml of ethanol:ether reagent c and heat in a 6ooc 
water bath for 30 minutes. 
11. Centrifuge at 10,000 rpm for 15 minutes at 40c and 
discard the supernatant (save for the lipids). 
12. Suspend the precipitate in 2 ml of 1 N KOH. 
13. Incubaate in a 370c water bath for 20 hours. 
14. Add 0.2 ml of HCl reaagent D and 1 ml TCA reagent E. 
15. Let stand for 30 minutes at 40c. 
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16. Centrifuge at 10,000 rpm for 20 minutes at 40c. 
17. The supernatant contains the hydrolyzed RNA and can be 
estimated by the orcinol procedure. 
18. suspend the precipitate in 5 ml of TCA reagent E. 
19. Heat in a 900c water bath with occasional stirring for 
minutes. 
20. Cool to 40c and let stand for 30 minutes at 40c. 
21. Centrifuge at 10,000 rpm for 20 minutes at 40c. 
22. The supernatant contains the DNA and it can be estimated 
by the diphenylamine reaction. 
Reagents 
A. 8.55 g of sucrose is diluted up to 100 ml with water 
(0.25 M). 
B. 10 g tricholroacetic acid is diluted up to 100 ml with 
water (10%). 
c. 90 ml ethanol+ 30 ml ethylether. 
D. 25 ml concentrated HCL added to 25 ml water (6 N). 
E. 5 g trichloroacetic acid diluted up to 100 ml with water. 
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